Arthrogryposis multiplex congenita
diseaseOn this page
Also known as AMCArthromyodysplasia congenitacongenital arthromyodysplasiafibrous ankylosis of multiple jointsGuerin-Stern syndromeGuérin-Stern syndromemultiple congenital arthrogryposismyodysplasiamyodystrophia fetalis deformansOtto syndromerocher-Sheldon syndromeRossi syndrome
Summary
Arthrogryposis multiplex congenita (MONDO:0015168) is a disease (an umbrella term covering 24 Mondo subtypes) caused by SENP7 (GenCC Strong), with 57 cohort genes and 4 clinical trials. The dominant Reactome pathway is Muscle contraction (7 cohort genes).
At a glance
- Prevalence: 1-9 / 100 000 (Europe) [Orphanet-validated]
- Causal gene: SENP7 (GenCC Strong)
- Umbrella term: 24 Mondo subtypes
- Cohort genes: 57
- ClinVar variants: 102
- Clinical trials: 4
Clinical features
Epidemiology
Prevalence records
3 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Prevalence at birth | 1-9 / 100 000 | 5.7 | Europe | Validated |
| Prevalence at birth | 1-9 / 100 000 | 8.3 | Australia | Validated |
| Prevalence at birth | 1-5 / 10 000 | Canada | Not yet validated |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | arthrogryposis multiplex congenita |
| Mondo ID | MONDO:0015168 |
| OMIM | 617468 |
| Orphanet | 1037 |
| DOID | DOID:0080954 |
| ICD-10-CM | Q74.3 |
| ICD-11 | 1930990330 |
| UMLS | C5779613 |
| MedGen | 1830310 |
| GARD | 0000777 |
| MedDRA | 10051643 |
| NORD | 810 |
| Is cancer (heuristic) | no |
Also known as: AMC · arthrogryposis multiplex congenita · Arthromyodysplasia congenita · congenital arthromyodysplasia · fibrous ankylosis of multiple joints · Guerin-Stern syndrome · Guérin-Stern syndrome · multiple congenital arthrogryposis · myodysplasia · myodystrophia fetalis deformans · Otto syndrome · rocher-Sheldon syndrome · Rossi syndrome
Data availability: 102 ClinVar variants · 4 GenCC gene-disease records.
Disease family
An umbrella term covering 24 Mondo subtypes.
Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › hereditary disease › arthrogryposis multiplex congenita
Related subtypes (1923): inherited bleeding disorder, platelet-type, infantile liver failure, febrile seizures, familial, hereditary hypophosphatemic rickets, hypothyroidism, congenital, nongoitrous, isolated microphthalmia, nephrolithiasis/osteoporosis, hypophosphatemic, anemia, hypochromic microcytic with iron overload, camptodactyly syndrome, Guadalajara, cerebelloparenchymal disorder, Chiari malformation, developmental dysplasia of the hip, bone marrow failure syndrome, Zimmermann-Laband syndrome, autoimmune disease, multisystem, infantile-onset, multinodular goiter, orofacial cleft, spondylocostal dysostosis, X-linked disease, Y-linked disease, autosomal genetic disease, cornea plana, epithelial-stromal TGFBI dystrophy, congenital diarrhea, Klippel-Feil syndrome, familial polycythemia, myopia, inherited aplastic anemia, FG syndrome, hypotrichosis, hereditary Wilms tumor, familial hemolytic anemia, hereditary fallopian tube carcinoma, ariboflavinosis, bronchiectasis, spermatogenic failure, preeclampsia, cataract, celiac disease, inflammatory bowel disease, ciliopathy, Fuchs’ endothelial dystrophy, hypospadias, bone Paget disease, visceral leishmaniasis, tooth agenesis, nanophthalmia, hydatidiform mole, fibromuscular dysplasia, familial abdominal aortic aneurysm, Adams-Oliver syndrome, Achard syndrome, Achoo syndrome, acroleukopathy, symmetric, acromegaloid changes, cutis verticis gyrata, and corneal leukoma, acromial dimples, adenosine triphosphatase deficiency, anemia due to, alopecia-epilepsy-pyorrhea-intellectual disability syndrome, amastia, bilateral, with ureteral triplication and dysmorphism, amelia and terminal transverse hemimelia, amenorrhea-galactorrhea syndrome, amyotrophic dystonic paraplegia, anal sphincter dysplasia, anal sphincter myopathy, internal, isolated aniridia, aniridia-absent patella syndrome, aniridia, microcornea, and spontaneously Reabsorbed cataract, anisocoria, ankyloglossia, diffuse idiopathic skeletal hyperostosis, annular erythema, anonychia-ectrodactyly, anonychia-onychodystrophy with brachydactyly type b and ectrodactyly, aortic arch interruption, facial palsy, and retinal coloboma, arcus senilis, arms, malformation of, arteries, anomalies of, arteriovenous malformations of the brain, arteritis, familial granulomatous, with juvenile polyarthritis, arthritis, sacroiliac, asymmetric short stature syndrome, PR interval, variation in, aurocephalosyndactyly, Axenfeld-Rieger anomaly with partially absent eye muscles, distinctive face, hydrocephaly, and skeletal abnormalities, azotemia, familial, gastroesophageal reflux disease, beta-amino acids, renal transport of, bladder diverticulum, blepharochalasis, superior, bone pain, periodic, Brachmann-de Lange-like facial changes with microcephaly, metatarsus adductus, and developmental delay, brachymesomelia-renal syndrome, Brachymetatarsus 4, Brachymorphism-onychodysplasia-dysphalangism syndrome, branchial myoclonus with spastic paraparesis and cerebellar ataxia, familial juvenile hypertrophy of the breast, bundle branch block, familial isolated complete right, butyrylesterase 1, Burkitt lymphoma, calcific aortic disease with immunologic abnormalities, familial, cancer, familial, with in vitro Radioresistance, canine teeth, absence of upper permanent, Car factor deficiency, Carabelli anomaly of maxillary molar teeth, carpal displacement, cervical hypertrichosis with underlying kyphoscoliosis, cervical rib disease, cervical vertebral Bridge, cervical vertebral dysplasia, chemodectoma, intraabdominal, with cutaneous angiolipomas, Chondronectin, choroidal osteoma, bilateral, cirrhosis, familial, congenital pseudoarthrosis of clavicle, aorta coarctation, coloboma, ocular, autosomal dominant, uveal coloboma-cleft lip and palate-intellectual disability, colonic varices without portal hypertension, comedones, familial Dyskeratotic, commissural lip pits, coracoclavicular joint, anomalous, cornea guttata with anterior polar cataracts, corneal degeneration, ribbonlike, with deafness, Schnyder corneal dystrophy, fleck corneal dystrophy, Meesmann corneal dystrophy, epithelial recurrent erosion dystrophy, coumarin resistance, coxa vara, cranioacrofacial syndrome, craniofacial-deafness-hand syndrome, craniorhiny, creatine phosphokinase, elevated serum, cryofibrinogenemia, familial primary, cryptotia, familial, isolated cryptophthalmia, Darwinian tubercle of pinna, autosomal dominant deafness - onychodystrophy syndrome, deafness-ear malformation-facial palsy syndrome, keratoderma hereditarium mutilans, deafness, mid-tone neural, deafness, sensorineural, with peripheral neuropathy and arterial disease, deafness, unilateral, deafness with anhidrotic ectodermal dysplasia, dens evaginatus, dens in dente and palatal invaginations, cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, dementia/parkinsonism with non-Alzheimer amyloid plaques, primary failure of tooth eruption, dentin dysplasia type I, dentin dysplasia type II, dentin dysplasia-sclerotic bones syndrome, deoxyribose-5-phosphate aldolase deficiency, dentinogenesis imperfecta type 2, dentinogenesis imperfecta type 3, dermal Ridges, patternless, diarrhea, glucose-stimulated secretory, with common variable immunodeficiency, diastema, dental medial, dilution, pigmentary, discrimination, Two-point, reduction 1N, distal osteosclerosis, distichiasis with congenital anomalies of the heart and peripheral vasculature, DNA, satellite, 3, DNA, low-repetitive sequences of, double nail for fifth toe, duodenal ulcer due to antral G-cell hyperfunction, duodenal ulcer, hyperpepsinogenemic 1, dwarfism, Levi type, dwarfism with stiff joints and ocular abnormalities, dystelephalangy, ear antitragus, tag at base of, ear exostoses, ear folding, ear malformation, preauricular fistulae, congenital, ear pits, posterior helical, thickened earlobes-conductive deafness syndrome, ectodermal dysplasia syndrome with distinctive facial appearance and preaxial polydactyly of feet, ectodermal dysplasia with adrenal cyst, ectopia lentis 1, isolated, autosomal dominant, ectopia pupillae, ectrodactyly and ectodermal dysplasia without cleft lip/palate, ectrodactyly-cleft palate syndrome, edema, familial idiopathic, prepubertal, electroencephalographic peculiarity: 14 and 6 per sec. positive spike phenomenon, electroencephalographic peculiarity: fronto-precentral beta wave groups, emphysema, hereditary pulmonary, eosinophilia, familial, Eosinophilopenia, epidermoid cysts, epidermolysis bullosa with deficiency of galactosylhydroxylysyl glucosyltransferase, epidermolysis bullosa with congenital localized absence of skin and deformity of nails, erythema nodosum, familial, esophageal ring, lower, exchondrosis of pinna, posterior, exostoses-anetodermia-brachydactyly type E syndrome, facial spasm, factor VIII and Factor IX, combined deficiency of, factors VIII, IX and XI, combined deficiency of, factor 9 and Factor XI, combined deficiency of, fibrinolytic defect, fibrodysplasia ossificans progressiva, fibula, recurrent dislocation of head of, Floating-Harbor syndrome, flushing of ears and somnolence, focal epithelial hyperplasia of the oral mucosa, fragile site 10Q23, Friedreich ataxia, so-called, with optic atrophy and sensorineural deafness, intellectual disability, FRA12A type, fucosidase regulator, gamma-A-globulin, defect in assembly of, Gamstorp-Wohlfart syndrome, gastric volvulus, intrathoracic, MALT lymphoma, gastric mucosal hypertrophy, genu valgum, st. Helena familial, giant neutrophil leukocytes, globulin anomaly involving beta (2A)-globulin, glomuvenous malformation, Glucoglycinuria, glucose-6-phosphate dehydrogenase-like, glutamic acid decarboxylase, brain, membrane form, glutathione transferase activity toward trans-stilbene oxide, hyperglycinuria, granddad syndrome, Grant syndrome, granulosis rubra nasi, graying of hair, precocious, guanylate kinase 3, hairy nose tip, hairy palms and soles, hand clasping pattern, cavernous hemangiomas of face-supraumbilical midline raphe syndrome, Kasabach-Merritt syndrome, oculoauriculovertebral spectrum with radial defects, hemolytic poikilocytic anemia due to reduced ankyrin binding sites, hemoglobin–variants for which the chain carrying the mutation 1S unknown or uncertain, hepatic adenomas, familial, hernia, double inguinal, heterochromia iridis, histiocytic dermatoarthritis, humeroradial synostosis, 5-hydroxytryptamine oxygenase regulator, orthostatic hypotensive disorder, Streeten type, hypercalciuria, absorptive, 2, hyperheparinemia, hyperhidrosis palmaris ET plantaris, hyperimmunoglobulin G1(A1) syndrome, hyperlipoproteinemia, type II, and deafness, hyperostosis cranialis interna, hyperpigmentation of eyelid, hyperpigmentation of Fuldauer and Kuijpers, hyperproglucagonemia, hyperreflexia, hypersecretion of adrenal androgens, familial, hypotaurinemic retinal degeneration and cardiomyopathy, essential hypertension, genetic, hyperthermia, cutaneous, with headaches and nausea, hyperthyroxinemia, dystransthyretinemic, hypertrophia musculorum vera, hypoparathyroidism-deafness-renal disease syndrome, hypophosphatemic bone disease, hypoxanthine guanine phosphoribosyltransferase suppressor, ichthyosis-cheek-eyebrow syndrome, IgE responsiveness, atopic, fused mandibular incisors, incisors, lower central, absence of, incisors, rotation of upper central, incisors, shovel-shaped, insensitivity to pain with hyperplastic Myelinopathy, insect Stings, hypersensitivity to, interferon antiviral depressor, iris pigment layer, cleavage of, islet cell adenomatosis, intussusception, IVIC syndrome, internal carotid artery, spontaneous dissection of, keloid formation, keratitis fugax hereditaria, keratosis, familial actinic, angioosteohypertrophic syndrome, knuckle pads, Kyrle disease, labia minora, incomplete adhesion of, lactic acidosis, chronic adult form, laryngeal adductor paralysis, lattice degeneration of retina leading to retinal detachment, periodic fever, immunodeficiency, and thrombocytopenia syndrome, leg ulcers, familial, of juvenile onset, lentiginosis, centrofacial neurodysraphic, leukocyte nuclear appendages, hereditary prevalence of, levator-medial rectus synkinesis, lip, hamartomatous, lipoprotein types–Lt system, lipoprotein, variant of beta, lithium transport, low density lipoprotein, variation in molecular weight of, lumbar stenosis, familial, macrocephaly, benign familial, myelodysplastic syndrome associated with isolated del(5q), malocclusion due to protuberant upper front teeth, Mammastatin, mannose 6-phosphate receptor recognition defect, Lebanese type, marfanoid hypermobility syndrome, masticatory muscles, hypertrophy of, maxillofacial dysostosis, Meckel diverticulum, mediosternal depigmentation line, megalodactyly, melanoma tumor antigen Gp90, mental and growth retardation with amblyopia, mesomelic dwarfism of hypoplastic tibia and radius type, metachondromatosis, metachromasia of fibroblasts, metatarsus varus, type 1, microphthalmia, isolated, with corectopia, microspherophakia with hernia, microspherophakia-metaphyseal dysplasia syndrome, milia, multiple eruptive, tooth ankylosis, MOMO syndrome, antigen defined by monoclonal antibody Aj9, antigen defined by monoclonal antibody T87, Monophalangy of great toe, nondisjunction, mullerian aplasia and hyperandrogenism, multiple exostoses with spastic tetraparesis, muscle cramps, familial, muscular atrophy, malignant neurogenic, muscular hypoplasia, congenital universal, of Krabbe, myelinated optic nerve fibers, myopathy with storage of glycoproteins and Glycosaminoglycans, nasal alar collapse, bilateral, nasal bones, absence of, nasal groove, familial transverse, nasal hyperpigmentation, familial transverse, neurofibromatosis-pheochromocytoma-duodenal carcinoid syndrome, neuropathy, congenital, with arthrogryposis multiplex, neuropathy, with paraprotein in serum, cerebrospinal fluid and urine, neutropenia, chronic familial, hereditary neutrophilia, nevus anemicus, nevus flammeus of nape of neck, nipples inverted, familial supernumerary nipples, noduli Cutanei, multiple, with urinary tract abnormalities, nose, anomalous shape of, onychogryposis, pedal, with keratosis plantaris and coarse hair, omphalocele, autosomal, ophthalmomandibulomelic dysplasia, ophthalmoplegia, familial static, ophthalmoplegia, familial total, with iris transillumination, ossified ear cartilages, ossicular malformations, familial, osteosclerosis with ichthyosis and fractures, otofaciocervical syndrome, ovalocytosis, hereditary hemolytic, with defective erythropoiesis, osteochondrodysplasia, rhizomelic, with callosal agenesis, thrombocytopenia, hydrocephalus, and hypertension, palmaris longus muscle, absence of, hereditary chronic pancreatitis, pancytopenia and occlusive vascular disease, papillomatosis, confluent and reticulated, papillomatosis, florid, of nipple, Paramolar tubercle of bolk, Parotidomegaly, hereditary bilateral, Passovoy factor defect, patella aplasia/hypoplasia, patella, familial recurrent dislocation of, Pechet factor deficiency, pectus excavatum, pelvic lipomatosis with crossed renal ectopia, pernicious anemia, peroneal nerve, accessory deep, peroxidase, salivary, phagocytosis, plasma-related defect 1N, pheochromocytoma-islet cell tumor syndrome, phlebectasia of lips, phocomelia-ectrodactyly-deafness-sinus arrhythmia syndrome, phosphatase, acid, of tissues, phosphoglucomutase 4, 6-phosphogluconolactonase deficiency, phosphoglycoprotein 1, photomyoclonus, diabetes mellitus, deafness, nephropathy, and cerebral dysfunction, Robin sequence-oligodactyly syndrome, pigmented purpuric eruption, pilonidal sinus, platelet adenylate cyclase activity, platelet aggregation, spontaneous, platelet disorder, undefined, platelet factor 3 deficiency, platelet membrane fluidity, platelet responsiveness to adrenaline, depressed, platelet signal processing defect, familial spontaneous pneumothorax, polyposis, intestinal, scattered and discrete, polyposis, intestinal, with multiple exostoses, polyps, multiple and recurrent inflammatory fibroid, gastrointestinal, popliteal cyst, postaxial tetramelic oligodactyly, posterior column ataxia, Guttmacher syndrome, familial male-limited precocious puberty, premature chromatid separation trait, presenile dementia, Kraepelin type, priapism, familial idiopathic, pronation-supination of the forearm, impairment of, proteolytic capacity of plasma, Protrusio acetabuli, pruritus, hereditary localized, pseudoarthrogryposis, Pseudoatrophoderma colli, pseudomonilethrix, pseudoxanthoma elasticum, forme fruste, pterygium colli, isolated, pubic bone dysplasia, pulmonary atresia with ventricular septal defect, pulmonic stenosis, atrial septal defect, and unique electrocardiographic abnormalities, pulmonic stenosis and deafness, pupillary membrane, persistence of, purpura simplex, radial heads, posterior dislocation of, radio-renal syndrome, radius, aplasia of, with cleft lip/palate, ragweed sensitivity, raindrop hypopigmentation, Raynaud disease, recombinant 8 syndrome, red cell permeability defect, red cell phospholipid defect with hemolysis, retinal venous beading, rhiny, ring dermoid of cornea, Rombo syndrome, Robinow-Sorauf syndrome, Roussy-Levy syndrome, Silver-Russell syndrome, aplasia of lacrimal and salivary glands, salivary substance, Clostridium botulinum type, salivary duct calculi, pleomorphic adenoma, cleft palate-large ears-small head syndrome, sella turcica, bridged, sister chromatid exchange, frequency of, skeletal dysplasia with delayed epiphyseal and carpal bone ossification, Somatomedin, embryonic, spastic paraplegia with associated extrapyramidal signs, spastic paraplegia, optic atrophy, and dementia, sperm protamine P4, spinocerebellar ataxia with rigidity and peripheral neuropathy, spinocerebellar atrophy with pupillary paralysis, splenogonadal fusion-limb defects-micrognathia syndrome, splenomegaly syndrome with splenic Germinal center hypoplasia and reduced circulating T helper cells, split lower lip, split-hand and split-foot with hypodontia, Karsch-Neugebauer syndrome, spondylolisthesis, spondylosis, cervical, polycystic ovary syndrome, sternum, premature obliteration of sutures of, storm syndrome, striae distensae, familial, surface antigen, glycoprotein 75, symphalangism of toes, surface polypeptides, anonymous, symphalangism, C. S. Lewis type, distal symphalangism, symphalangism with multiple anomalies of hands and feet, synovial chondromatosis, familial, with dwarfism, syringomas, multiple, talonavicular coalition, tarsal coalition, tear protein, anodal, T-cell Subgroups, non-HLA-linked, teeth, odd shapes of, teeth present at birth, teeth, supernumerary, temperature-sensitive lethal mutation, spermatic cord torsion, tetralogy of fallot and glaucoma, tetramelic monodactyly, thumb deformity, thyroid hormone plasma membrane transport defect, tibial torsion, bilateral medial, toe, fifth, number of phalanges 1N, toe, misshapen, toe, rotated fifth, toes, relative length of first and second, toes, space between first and second, malposition of teeth with or without hypodontia/oligodontia, torus palatinus and torus mandibularis, tremor of intention, ataxia, and lipofuscinosis, trichomegaly, trichoepitheliomas, multiple desmoplastic, trigger thumb, triphalangeal thumb with double phalanges, triphalangeal thumb, Nonopposable, Tristichiasis, humerus trochlea aplasia, Tuftsin deficiency, suppressor of tumorigenicity 3, tune deafness, Undritz anomaly, Upington disease, ureter, bifid or double, ureterocele, urolithiasis, uric acid, autosomal dominant, urinary bladder, atony of, uterine anomalies, vascular helix of umbilical cord, veins, pattern of, on anterior thorax, venular insufficiency, systemic, vertebral hypoplasia with lumbar kyphosis, congenital vertical talus, vestibulocochlear dysfunction, progressive, volvulus of midgut, Woronets trait, ablepharon macrostomia syndrome, familial glucocorticoid deficiency, aganglionosis, total intestinal, agenesis of cerebral white matter, agnathia-otocephaly complex, Moynahan syndrome, alopecia - intellectual disability syndrome, amino aciduria with mental deficiency, dwarfism, muscular dystrophy, osteoporosis, and acidosis, Amobarbital, deficient N-hydroxylation of, amyloidosis of gingiva and conjunctiva, with intellectual disability, gelatinous drop-like corneal dystrophy, amyloidosis, cutaneous bullous, angiomatosis, diffuse Corticomeningeal, of Divry and van Bogaert, aniridia-renal agenesis-psychomotor retardation syndrome, anodontia, anosmia for isobutyric acid, antithrombin, familial hemorrhagic diathesis due to, Aphalangy-hemivertebrae-urogenital-intestinal dysgenesis syndrome, arteriosclerosis, severe juvenile, arthrogryposis, distal, with intellectual disability and characteristic facies, asthma, nasal polyps, and aspirin intolerance, asthma, short stature, and elevated IgA, ataxia with myoclonic epilepsy and presenile dementia, ataxia, deafness, and cardiomyopathy, ataxia-microcephaly-cataract syndrome, atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome, Athrombia, essential, atonic-astatic syndrome of Foerster, atrichia with papular lesions, berry aneurysm, cirrhosis, pulmonary emphysema, and cerebral calcification, beta-aminoisobutyric acid, urinary excretion of, biliary malformation with renal tubular insufficiency, Bowen syndrome of multiple malformations, brachydactyly, type A2, with microcephaly, Elsahy-Waters syndrome, Sabinas brittle hair syndrome, hereditary arterial and articular multiple calcification syndrome, camptodactyly-ichthyosis syndrome, congenital disorder of glycosylation, type i/IIx, carboxypeptidase N deficiency, cardiac septal defects with coarctation of the aorta, cardioauditory syndrome of Sanchez Cascos, cardiomyopathy associated with myopathy and sudden death, carnitine deficiency, myopathic, colobomatous optic disc-macular atrophy-chorioretinopathy syndrome, premature centromere division, cephalin lipidosis, cerebellar ataxia and neurosensory deafness, cerebellar ataxia, benign, with thermoanalgesia, cerebral angiopathy, dysphoric, cerebral malformation, seizures, hypertrichosis, and overlapping fingers, cerebrocortical degeneration of infancy, cervical vertebrae, agenesis of, CHAND syndrome, Charcot-Marie-Tooth disease-hearing loss-intellectual disability syndrome, cholestasis with gallstone, ataxia, and visual disturbance, cholesterol pneumonia, chondroitin-6-sulfaturia, defective cellular immunity, nephrotic syndrome, central areolar choroidal dystrophy, chromosomal instability with tissue-specific radiosensitivity, circumvallate placenta syndrome, citrulline transport defect, Juberg-Hayward syndrome, coloboma, ocular, autosomal recessive, Jalili syndrome, convulsive disorder, familial, with prenatal or early onset, corneal dystrophy-perceptive deafness syndrome, corneal degeneration, band-shaped spheroid, congenital hereditary endothelial dystrophy of cornea, Crane-Heise syndrome, cranial nerves, congenital paresis of, cranial nerves, recurrent paresis of, temtamy syndrome, craniosynostosis with anomalies of the cranial base and digits, craniosynostosis-intellectual disability syndrome of 51N and Gettig, craniosynostosis-intellectual disability-clefting syndrome, cryptorchidism, curved nail of fourth toe, Cushing syndrome due to macronodular adrenal hyperplasia, cutis verticis gyrata and intellectual disability, cyanosis and hepatic disease, cysteine Peptiduria, cystic disease of lung, ventriculomegaly-cystic kidney disease, deafness, congenital, and familial myoclonic epilepsy, DOORS syndrome, high myopia-sensorineural deafness syndrome, conductive deafness-malformed external ear syndrome, deafness-vitiligo-achalasia syndrome, deafness-small bowel diverticulosis-neuropathy syndrome, deafness, neural, congenital moderate, deafness, neural, with atypical atopic dermatitis, dextrocardia with unusual facies and microphthalmia, diaminopentanuria, disseminated sclerosis with narcolepsy, Dohle bodies and leukemia, dwarfism, low-birth-weight type, with unresponsiveness to growth hormone, dwarfism, intellectual disability, and eye abnormality, dwarfism, proportionate, with hip dislocation, dysautonomia-like disorder, dysmyelination with jaundice, dystonia with Ringbinden, ectopia lentis 2, isolated, autosomal recessive, ectopia lentis et pupillae, encephalomalacia, multilocular, Fowler syndrome, endocardial fibroelastosis and coarctation of abdominal aorta, endothelial dystrophy, congenital hereditary, with nail hypoplasia, enterocolitis, congenital enteropathy due to enteropeptidase deficiency, protein-losing enteropathy, epidermolysis bullosa with diaphragmatic hernia, epilepsy, photogenic, with spastic diplegia and intellectual disability, celiac disease-epilepsy-cerebral calcification syndrome, epiphyseal dysplasia of femoral head, myopia, and deafness, epithelial squamous dysplasia, keratinizing desquamative, of urinary tract, immunodeficiency 32B, erythema of acral regions, ethanolaminosis, facial abnormalities, kyphoscoliosis, and intellectual disability, lethal faciocardiomelic dysplasia, faciothoracogenital syndrome, Fanconi-like syndrome, fever, familial lifelong persistent, fibrosclerosis, multifocal, focal epithelial hyperplasia, Fraser-like syndrome, Freesia Flowers, inability to smell, Friedreich ataxia and congenital glaucoma, fructose and galactose intolerance, monosodium glutamate sensitivity, gluteal muscles, absence of, GOMBO syndrome, granulocytopenia with immunoglobulin abnormality, grouped pigmentation of the retina, Halothane hepatitis, hemangiomatosis, cutaneous, with associated features, hepatic veno-occlusive disease-immunodeficiency syndrome, Hirschsprung disease with ulnar polydactyly, polysyndactyly of big toes, and ventricular septal defect, familial lipochrome histiocytosis, classic Hodgkin lymphoma, Hooft disease, Hutterite cerebroosteonephrodysplasia syndrome, hydroxyprolinemia, hymen, imperforate, Leydig cell hypoplasia, type 1, hyperleucine-Isoleucinemia, hyperlysinuria with hyperammonemia, hypermetabolism due to defect in mitochondria, hyperopia, high, hyperparathyroidism, neonatal self-limited primary, with hypercalciuria, hyperphosphatemia, polyuria, and seizures, hypertelorism and tetralogy of fallot, hypertrophic neuropathy and cataract, hyperuricemia, infantile, with abnormal behavior and normal hypoxanthine guanine phosphoribosyltransferase, hypoglycemia, leucine-induced, hypoinsulinemic hypoglycemia and body hemihypertrophy, hypogonadism with low-grade mental deficiency and microcephaly, hypogonadism, male, hypohidrosis with abnormal palmar dermal Ridges, hypokalemic alkalosis, familial, with specific renal tubulopathy, hypophosphatemia, renal, with intracerebral calcifications, hypopituitarism, congenital, with central diabetes insipidus, Bamforth-Lazarus syndrome, ichthyosis congenita with biliary atresia, ichthyosis-intellectual disability-dwarfism-renal impairment syndrome, ichthyosis, split hairs, and amino aciduria, immunoglobulin d level in plasma, low, channelopathy-associated congenital insensitivity to pain, autosomal recessive, indolylacroyl glycinuria with intellectual disability, inosine phosphorylase deficiency, immune defect due to, internal carotid arteries, hypoplasia of, immunodeficiency with defective T-cell response to interleukin 1, acetylation, slow, isovaleric acid, inability to smell, Jumping Frenchmen of Maine, oculocerebrofacial syndrome, Kaufman type, keratoconus and congenital hip dysplasia, keratoconus posticus circumscriptus, Kniest-like dysplasia with pursed lips and ectopia lentis, Kifafa seizure disorder, specific granule deficiency, Lambotte syndrome, absence deformity of leg-cataract syndrome, leukemia, acute myelocytic, with polyposis coli and colon cancer, lymphoid system deterioration, progressive, lymphopenic hypergammaglobulinemia, antibody deficiency, autoimmune hemolytic anemia, and glomerulonephritis, lysine malabsorption syndrome, macroepiphyseal dysplasia with osteoporosis, wrinkled skin, and aged appearance, macrosomia adiposa congenita, magnesium, elevated red cell, malocclusion and short stature, mandibulofacial dysostosis with mental deficiency, oculotrichoanal syndrome, megaepiphyseal dwarfism, megalencephaly with dysmyelination, megalocornea, mesoaxial hexadactyly and cardiac malformation, metaphyseal chondrodysplasia, Pena type, metaphyseal dysplasia, anetoderma, and optic atrophy, metaphyseal modeling abnormality, skin lesions, and spastic paraplegia, methionine malabsorption syndrome, microcephaly-micromelia syndrome, Jawad syndrome, microphthalmia with hyperopia, retinal degeneration, macrophakia, and dental anomalies, microtia with meatal atresia and conductive deafness, mucus inspissation of respiratory tract, muscular dystrophy, adult-onset, with leukoencephalopathy, muscular hypertonia, lethal, musk, inability to smell, myeloperoxidase deficiency, myopathy, granulovacuolar lobular, with electrical myotonia, myopathy due to malate-aspartate shuttle defect, myopathy with giant abnormal mitochondria, Keipert syndrome, nephropathy - deafness - hyperparathyroidism syndrome, neuroectodermal melanolysosomal disease, neurologic disease, infantile multisystem, with osseous fragility, neuropathy, hereditary motor and sensory, with excessive myelin folding complex, autosomal recessive, neuropathy, painful, obesity-hypoventilation syndrome, ocular myopathy with curare sensitivity, oculocerebral hypopigmentation syndrome of Preus, oculorenocerebellar syndrome, olivopontocerebellar atrophy II, autosomal recessive, Onychotrichodysplasia and neutropenia, ophthalmoplegia totalis with ptosis and miosis, ophthalmoplegic neuromuscular disorder with abnormal mitochondria, optic atrophy, hearing loss, and peripheral neuropathy, autosomal recessive, Opticocochleodentate degeneration, oral sensibility, disturbance of, Primrose syndrome, osteodysplasty, precocious, of Danks, Mayne, and Kozlowski, congenital osteogenesis imperfecta-microcephaly-cataracts syndrome, osteoma of middle ear, otoonychoperoneal syndrome, palant cleft palate syndrome, pancreatic agenesis, pancreatitis, sclerosing cholangitis, and sicca complex, Partington-Anderson syndrome, pellagra-like syndrome, periodontitis, chronic, adult, peripheral neuropathy, ataxia, focal necrotizing encephalopathy, and spongy degeneration of brain, peroneus tertius muscle, absence of, phenformin 4-hydroxylation, Rabson-Mendenhall syndrome, pituitary dwarfism with large sella turcica, plasma clot retraction factor, deficiency of, platelet prostacyclin receptor defect, pleoconial myopathy with salt craving, polycystic kidney, cataract, and congenital blindness, polymyoclonus, infantile, polysaccharide, storage of unusual, polyhydramnios, chronic idiopathic, Prepapillary vascular loops, progesterone resistance, prolactin deficiency, isolated, prolactin deficiency with obesity and enlarged testes, prune belly syndrome with pulmonic stenosis, intellectual disability, and deafness, 46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency, Pseudouridinuria and mental defect, pulmonary alveolar microlithiasis, pulmonary atresia-intact ventricular septum syndrome, pulmonary bullae causing pneumothorax, pulmonary venoocclusive disease, pulmonic stenosis, pulmonic stenosis and congenital nephrosis, pyloric atresia, pyropoikilocytosis, hereditary, radiculoneuropathy, fatal neonatal, Ramon syndrome, red skin pigment anomaly of new guinea, Reese retinal dysplasia, renal and mullerian duct hypoplasia, Perlman syndrome, respiratory underresponsiveness to hypoxia and hypercapnia, retinal degeneration and epilepsy, retinal telangiectasia and hypogammaglobulinemia, retinitis pigmentosa inversa with deafness, retinitis pigmentosa-intellectual disability-deafness-hypogenitalism syndrome, retinopathy, pigmentary, and intellectual disability, rod-cone dystrophy, sensorineural deafness, and Fanconi-type renal dysfunction, Rowley-Rosenberg syndrome, second metatarsal-metacarpal syndrome, senile plaque formation, short stature-obesity syndrome, Sjogren-Larsson-like ichthyosis without CNS or eye involvement, sodium-potassium-ATPase activity of red cell, growth delay due to insulin-like growth factor I resistance, ataxia, spastic, childhood-onset, autosomal recessive, with optic atrophy and intellectual disability, spastic diplegia and intellectual disability, spastic paraplegia with myoclonic epilepsy, spastic tetraplegia-retinitis pigmentosa-intellectual disability syndrome, spinal muscular atrophy with intellectual disability, spinal muscular atrophy with microcephaly and mental subnormality, familial isolated congenital asplenia, splenoportal vascular anomalies, spondylocostal dysostosis-anal and genitourinary malformations syndrome, subaortic stenosis, membranous, sucrosuria, hiatus hernia and intellectual disability, syndesmodysplasic dwarfism, tardive dyskinesia, taurodontism, teeth, fused, testes, rudimentary, tetraamelia with ectodermal dysplasia and lacrimal duct abnormalities, tetraamelia-multiple malformations syndrome, thalamic degeneration, symmetric infantile, thumb, distal hyperextensibility of, thymic aplasia with fetal death, thymoma, familial, tiglic acidemia, tibia, absence of, with congenital deafness, tongue, pigmented fungiform papillae of, Tryptophanuria with dwarfism, T-substance anomaly, Tyrosinosis, ulna hypoplasia-intellectual disability syndrome, ulnar agenesis and endocardial fibroelastosis, Valinemia, van Bogaert-Hozay syndrome, vascular hyalinosis, isolated right ventricular hypoplasia, vitiligo, progressive, with intellectual disability and urethral duplication, de Sanctis-Cacchione syndrome, xylosidase deficiency, Young syndrome, corpus callosum agenesis-abnormal genitalia syndrome, intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked, CGF1, arthrogryposis, congenital, lower limb, X-linked, hypotonia, congenital nystagmus, ataxia, and abnormal auditory brainstem responses, Simpson-Golabi-Behmel syndrome type 2, episodic muscle weakness, X-linked, radioulnar synostosis, radial ray abnormalities, and severe malformations in the male, Christianson syndrome, Armfield syndrome, radial ray deficiency, X-linked, alpha-thalassemia-myelodysplastic syndrome, cataract, ataxia, short stature, and intellectual disability, Tn polyagglutination syndrome, fragile X syndrome, deafness, cataract, retinitis pigmentosa, and sperm abnormalities, Lisch epithelial corneal dystrophy, synovial sarcoma, cardiomyopathy, fatal fetal, due to myocardial calcification, X-linked dominant chondrodysplasia, Chassaing-Lacombe type, immunodeficiency 47, Meester-Loeys syndrome, midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis, Arts syndrome, tubulin, beta, bullous dystrophy, macular type, Nance-Horan syndrome, central incisors, absence of, Charcot-Marie-Tooth peroneal muscular atrophy, X-linked, with aplasia cutis congenita, Abruzzo-Erickson syndrome, X-linked complicated corpus callosum dysgenesis, cutis verticis gyrata, thyroid aplasia, and intellectual disability, immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome, focal dermal hypoplasia, glutamyl ribose-5-phosphate storage disease, granulomas, congenital cerebral, hemopoietic proliferation, Hhhh syndrome, ichthyosis and male hypogonadism, immunodeficiency, X-linked, with deficiency of 115,000 Dalton surface glycoprotein, immunoglobulin M, level of, impacted teeth, multiple, imprinting gene related to retinoblastoma, jaundice, familial obstructive, of infancy, Kallmann syndrome with spastic paraplegia, modifier, X-linked, for Neurofunctional defects, myelolymphatic insufficiency, nuclear ribonucleic acid, occipital hair, white lock of, omphalocele, X-linked, ophthalmoplegia, external, and myopia, optic atrophy–spastic paraplegia syndrome, Paine syndrome, Pierre Robin syndrome-faciodigital anomaly syndrome, properdin deficiency, X-linked, absent radius-anogenital anomalies syndrome, radiation sensitivity of natural killer activity, reticuloendotheliosis, X-linked, spastic paraparesis-deafness syndrome, spatial visualization, aptitude for, Taqi polymorphism, taurodontism, microdontia, and dens invaginatus, thrombocytopenia with elevated serum IgA and renal disease, thumbs, congenital Clasped, ulnar hypoplasia-split foot syndrome, unique green phenomenon, VACTERL association, X-linked, with or without hydrocephalus, widow’s peak syndrome, hairy ears, Y-linked, ubiquitin-activating enzyme, Y-linked, hypomagnesemia, hypertension, and hypercholesterolemia, mitochondrial, cardiomyopathy, infantile hypertrophic, chloramphenicol toxicity, nephropathy, chronic tubulointerstitial, pancreatic hypoplasia-diabetes-congenital heart disease syndrome, macrocytosis, familial, pancreatic beta cell agenesis with neonatal diabetes mellitus, chondrodysplasia-pseudohermaphroditism syndrome, familial caudal dysgenesis, gonadal agenesis, succinic acidemia, parotid salivary glands, polycystic dysgenetic disease of, enteropathy, familial, with villous edema and immunoglobulin G2 deficiency, pachydermodactyly, familial, angiokeratoma corporis diffusum with arteriovenous fistulas, pigment dispersion syndrome, setting-Sun phenomenon, familial benign, enuresis, nocturnal, 1, varicella, severe recurrent, dwarfism, familial, with muscle spasms, isoproterenol-mediated vasodilatation, nocturnal enuresis, 2, mitochondrial import-stimulating factor, hereditary hyperferritinemia with congenital cataracts, ectodermal dysplasia with intellectual disability and syndactyly, enamel hypoplasia, cataracts, and aqueductal stenosis, protocadherin 3, cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies, portal vein, cavernous transformation of, midline malformations, multiple, with limb abnormalities and hypopituitarism, ichthyosis-intellectual disability syndrome with large keratohyalin granules in the skin, Ayme-Gripp syndrome, guanylate cyclase 2E, trisomy 18-like syndrome, muscular dystrophy, congenital, with severe central nervous system atrophy and absence of large myelinated fibers, osteoporosis-oculocutaneous hypopigmentation syndrome, myeloid tumor suppressor, epithelial basolateral chloride conductance regulator, rabbit, homolog of, atrophia maculosa varioliformis cutis, familial, spinal dysplasia, Anhalt type, Martinez-Frias syndrome, myelodysplasia, immunodeficiency, facial dysmorphism, short stature, and psychomotor delay, ectrodactyly of lower limbs, congenital heart defect, and micrognathia, short stature, Brussels type, deafness-epiphyseal dysplasia-short stature syndrome, amelia cleft lip palate hydrocephalus iris coloboma, distal monosomy 10p, cervical ribs, Sprengel anomaly, anal atresia, and urethral obstruction, microcephaly, corpus callosum dysgenesis, and cleft lip/palate, anterior chamber cleavage disorder, cerebellar hypoplasia, hypothyroidism, and tracheal stenosis, progressive deafness with stapes fixation, patent ductus venosus, ribbing disease, microcephaly, retinitis pigmentosa, and sutural cataract, facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome, spastic paraplegia and Evans syndrome, iris pigment epithelium anomalies, acute insulin response, sebaceous gland hyperplasia, familial presenile, superior transverse scapular ligament, calcification of, familial, Spondylospinal thoracic dysostosis, acroosteolysis-keloid-like lesions-premature aging syndrome, vacuolar Neuromyopathy, sperm-specific antigen 1, otofacioosseous-gonadal syndrome, broad terminal phalanges, familial, capillary infantile hemangioma, medium chain 3-ketoacyl-Coa thiolase deficiency, ventriculomegaly with defects of the radius and kidney, mitochondrial intermembrane space protein Tim12, yeast, homolog of, sensorineural hearing loss, retinal pigment epithelium lesions, discolored teeth, Weyers ulnar ray/oligodactyly syndrome, creases, infra-auricular cutaneous, with tall stature and advanced bone age, pseudoacromegaly with severe insulin resistance, grange syndrome, jejunal atresia with renal adysplasia, microcephaly, macrotia, and intellectual disability, facial dysmorphism, cleft palate, hearing loss, and camptodactyly, brachydactyly, intraventricular septal defect, and deafness, emphysema, congenital, with deafness, penoscrotal web, and intellectual disability, pancreatic lymphoma, familial, camptodactyly, myopia, and fibrosis of the medial rectus muscle of eye, skeletal dysplasia and progressive central nervous system degeneration, lethal, intellectual disability, severe, with spasticity and pigmentary tapetoretinal degeneration, tumor suppressor gene on chromosome 11, spastic paraplegia, optic atrophy, microcephaly, and 10Y sex reversal, apraxia of eyelid opening, dislocated elbows, bowed tibias, scoliosis, deafness, cataract, microcephaly, and intellectual disability, muscular dystrophy, congenital, with cerebellar atrophy, GRACILE syndrome, familial gestational hyperthyroidism, long chain fatty acids, defect in transport of, Osebold skeletal dysplasia/osteolysis syndrome, osteosclerotic chondrodysplasia, lethal, with intracellular inclusions, microcephaly, severe, with skeletal anomalies including posterior rib-Gap defects, Tonoki syndrome, expansile bone lesions, Oroacral syndrome, Verloes-Koulischer type, Dyserythropoiesis, congenital, with ultrastructurally normal erythroblast heterochromatin, microcephaly, facial abnormalities, micromelia, and intellectual disability, follicular atrophoderma, perioral pigmented, with milia and epidermoid cysts, parotitis, juvenile recurrent, facial dysmorphism, selective tooth agenesis, and choroid calcification, osteoma of cranial vault, familial, neuroendocrine carcinoma of salivary glands, sensorineural hearing loss, and enamel hypoplasia, atrial septal defect, secundum, with various cardiac and Noncardiac defects, exostosis, Dupuytren subungual, eccrine syringofibroadenomatosis with eyelid abnormalities, blue nevi, familial multiple, blepharophimosis - intellectual disability syndrome, SBBYS type, Acrodysplasia with ossification abnormalities, short stature, and fibular hypoplasia, intervertebral disk degenerative disorder, Caronte, cholesteatoma, congenital, Hirschsprung disease with heart defects, laryngeal anomalies, and preaxial polydactyly, Chudley-McCullough syndrome, camera-Marugo-Cohen syndrome, anemia, congenital hypoplastic, with multiple congenital anomalies/intellectual disability syndrome, myoclonic epilepsy, congenital deafness, macular dystrophy, and psychiatric disorders, ulnar ray dysgenesis with postaxial polydactyly and renal cystic dysplasia, lissencephaly, familial, with cleft palate and cerebellar hypoplasia, polyneuropathy, lethal neonatal, axonal sensorimotor, autosomal recessive, growth and developintellectual disability, ocular ptosis, cardiac defect, and anal atresia, polycystic bone disease, mandibulofacial dysostosis syndrome, Bauru type, hyaluronan metabolism, defect 1N, wormian bone-multiple fractures-dentinogenesis imperfecta-skeletal dysplasia, Wolfram syndrome 2, diabetes mellitus, congenital autoimmune, low density lipoprotein cholesterol, mild elevation of, clavicular hypoplasia, zygomatic arch hypoplasia, and micrognathia, early response to neural induction gene, pseudohyperaldosteronism type 2, Wiedemann-Steiner syndrome, frontoocular syndrome, fibromatosis, gingival, with hypertrichosis and intellectual disability, tetralogy of fallot syndrome, autosomal recessive, anisomastia, ovarian dysgenesis, hypergonadotropic, with short stature and recurrent metabolic acidosis, short stature, intellectual disability, callosal agenesis, Heminasal hypoplasia, microphthalmia, and atypical clefting, arthropathy, erosive, liver fibrocystic disease and polydactyly, crumpled helices and small mouth, acromegaloid features, overgrowth, cleft palate, and hernia, Sener syndrome, baculum, congenital absence of, carnitine acetyltransferase deficiency, laryngeal abductor paralysis with cerebellar ataxia and motor neuropathy, intellectual disability, short stature, facial anomalies, and joint dislocations, Phelan-McDermid syndrome, intellectual disability, microcephaly, growth retardation, joint contractures, and facial dysmorphism, alveolar soft part sarcoma, pathological gambling, Megarbane syndrome, partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome, gastrointestinal stromal tumor, hemifacial myohyperplasia, peripheral arterial occlusive disease 1, parasomnia, sleep bruxism type, Cardioneuromyopathy with hyaline masses and nemaline rods, Cree intellectual disability syndrome, primary intraosseous venous malformation, duodenojejunal atresia with volvulus, absent dorsal mesentery, and absent superior mesenteric artery, symphalangism, distal, with microdontia, dental pulp stones, and narrowed zygomatic arch, COPD, severe early onset, laryngeal atresia, encephalocele, and limb deformities, epilepsy, partial, with pericentral spikes, hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration, horizontal gaze palsy with progressive scoliosis, streptococcus, group A, severity of infection by, thyroid Hurthle cell carcinoma, headache associated with sexual activity, Camptosynpolydactyly, complex, secretory diarrhea, myopathy, and deafness, spastic paraplegia, ataxia, and intellectual disability, breath-holding Spells, prostate cancer aggressiveness quantitative trait locus on chromosome 19, microphthalmia with cyst, bilateral facial clefts, and limb anomalies, cataract, congenital, with mental impairment and dentate gyrus atrophy, craniolenticulosutural dysplasia, nonimmune chronic idiopathic neutropenia of adults, caudal duplication, Thai symphalangism syndrome, bile and pancreatic ducts, complete absence of, ovarian hyperstimulation syndrome, zinc deficiency, transient neonatal, aspirin resistance, mandibulofacial dysostosis with ptosis, autosomal dominant, parathyroid gland carcinoma, growth failure, microcephaly, intellectual disability, cataracts, large joint contractures, osteoporosis, cortical dysplasia, and cerebellar atrophy, scimitar anomaly, multiple cardiac malformations, and craniofacial and central nervous system abnormalities, capillary malformation-arteriovenous malformation syndrome, speech-sound disorder, alopecia universalis congenita, 10Y gonadal dysgenesis, and laryngomalacia, choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome, brachial palsy, familial congenital, oligodontia-cancer predisposition syndrome, midface hypoplasia, obesity, developmental delay, and neonatal hypotonia, ichthyosis prematurity syndrome, intellectual disability-brachydactyly-Pierre Robin syndrome, neuropathy, hereditary sensory and autonomic, adult-onset, with anosmia, growth delay due to insulin-like growth factor type 1 deficiency, sudden infant death-dysgenesis of the testes syndrome, leukoencephalopathy, arthritis, colitis, and hypogammaglobulinema, metaphyseal undermodeling, spondylar dysplasia, and overgrowth, lateral semicircular canal malformation, familial, with external and middle ear abnormalities, Meacham syndrome, marfanoid habitus with situs inversus, peripheral cone dystrophy, Emanuel syndrome, intellectual disability with optic atrophy, facial dysmorphism, microcephaly, and short stature, skeletal dysplasia, rhizomelic, with retinitis pigmentosa, familial hyperthyroidism due to mutations in TSH receptor, umbilicus, familial flat, dandy-walker malformation with occipital cephalocele, autosomal dominant, hypotrichosis, progressive patterned scalp, with wiry hair, onycholysis, and cleft lip/palate, syncope, familial vasovagal, B-cell immunodeficiency, distal limb anomalies, and urogenital malformations, chromosome 18 pericentric inversion, colloid cysts of third ventricle, intellectual disability, keratoconus, febrile seizures, and sinoatrial block, Goldberg-Shprintzen syndrome, cleft palate, midfacial hypoplasia, triangular facies, and sensorineural hearing loss, nephropathy, progressive, with deafness, iridogoniodysgenesis and skeletal anomalies, omphalocele, diaphragmatic hernia, and radial ray defects, spondylomegaepiphyseal dysplasia with upper limb mesomelia, punctate calcifications, and deafness, Nguyen syndrome, trichilemmal cyst, short stature and Facioauriculothoracic malformations, 7q11.23 microduplication syndrome, hamartoma, Precalcaneal congenital fibrolipomatous, vasculitis, lymphocytic, cutaneous small vessel, ectodermal dysplasia, sensorineural hearing loss, and distinctive facial features, brachyphalangy, polydactyly, and tibial aplasia/hypoplasia, metaphyseal chondrodysplasia with cone-shaped epiphyses, normal hair, and normal hands, trichoscyphodysplasia, arthrogryposis multiplex with deafness, inguinal hernias, and early death, brachydactyly, coloboma, and anterior segment dysgenesis, congenital stromal corneal dystrophy, Devriendt syndrome, MORM syndrome, kyphoscoliosis 1, esophagitis, eosinophilic, 1, alcohol sensitivity, acute, Kleefstra syndrome, rhizomelic dysplasia, scoliosis, and retinitis pigmentosa, right pulmonary artery, anomalous origin of, familial, preauricular tag, isolated, autosomal dominant, 1, testicular microlithiasis, Koolen-de Vries syndrome, preterm premature rupture of the membranes, insulin-resistance syndrome type A, corticosterone methyloxidase type 2 deficiency, holoprosencephaly, recurrent infections, and monocytosis, deafness with labyrinthine aplasia, microtia, and microdontia, iris pattern, epiphyseal dysplasia, Baumann type, Polyosteolysis-hyperostosis syndrome, Sakoda complex, Potocki-Lupski syndrome, hereditary pulmonary alveolar proteinosis, craniofacial dysplasia - osteopenia syndrome, Mungan syndrome, Tented eyebrows, corticosteroid-binding globulin deficiency, familial cavitary optic disk anomaly, renal tubular acidosis, distal, with nephrocalcinosis, short stature, intellectual disability, and distinctive facies, peripapillary atrophy, beta type, dystonia with cerebellar atrophy, Dauwerse-Peters syndrome, tremor, hereditary essential, and idiopathic normal pressure hydrocephalus, mesomelic dysplasia, camera type, Stevenson-Carey syndrome, Hunter-Macdonald syndrome, hypophosphatemic rickets and hyperparathyroidism, deafness, unilateral, with delayed endolymphatic hydrops, histiocytoma, Angiomatoid fibrous, diastasis recti and weakness of the linea alba, Ewing sarcoma, extraskeletal myxoid chondrosarcoma, bilateral microtia-deafness-cleft palate syndrome, Pseudofolliculitis barbae, skeletal defects, genital hypoplasia, and intellectual disability, endocrine-cerebro-osteodysplasia syndrome, cholestasis-pigmentary retinopathy-cleft palate syndrome, faciocardiomelic syndrome, hypotonia, seizures, and precocious puberty, Megarbane-Jalkh syndrome, Giacheti syndrome, lethal polymalformative syndrome, Boissel type, microcephaly, growth retardation, cataract, hearing loss, and unusual appearance, Stargardt macular degeneration, absent or hypoplastic corpus callosum, intellectual disability, and dysmorphic features, Santos syndrome, CLAPO syndrome, hereditary hypotrichosis with recurrent skin vesicles, hydrops fetalis, nonimmune, with gracile bones and dysmorphic features, trichotillomania, Pseudopili annulati, bile acid malabsorption, primary, 1, syndromic multisystem autoimmune disease due to ITCH deficiency, Birbeck granule deficiency, Warsaw breakage syndrome, chromosome 15q24 deletion syndrome, esophagitis, eosinophilic, 2, Reynolds syndrome, early repolarization associated with ventricular fibrillation, chromosome 4Q32.1-q32.2 triplication syndrome, forsythe-wakeling syndrome, lymphedema-posterior choanal atresia syndrome, agenesis of the corpus callosum and congenital lymphedema, brachydactyly, type A1, with short stature, scoliosis, microcephaly, ptosis, hearing loss, and intellectual disability, odontoid hypoplasia, cocoon syndrome, tuberculin skin test reactivity, absence of, intellectual disability, anterior maxillary protrusion, and strabismus, THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome, mammary-digital-nail syndrome, supernumerary der(22)t(8;22) syndrome, porencephaly-microcephaly-bilateral congenital cataract syndrome, chromosome 1p32-p31 deletion syndrome, Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency, multisystemic smooth muscle dysfunction syndrome, inosine triphosphatase deficiency, fucosyltransferase 6 deficiency, Hirschsprung disease, cardiac defects, and autonomic dysfunction, obesity, hyperphagia, and developmental delay, lipodystrophy, partial, acquired, with low complement component c3, with or without glomerulonephritis, acetyl-coa carboxylase deficiency, Okt4 epitope deficiency, cyanosis, transient neonatal, protein Z deficiency, hydroxyacyl glutathione hydrolase deficiency, trypsinogen deficiency, acetyl-CoA acetyltransferase-2 deficiency, N-acetylaspartate deficiency, anhaptoglobinemia, plasma fibronectin deficiency, recurrent infections associated with rare immunoglobulin isotypes deficiency, hyperbiliverdinemia, myostatin-related muscle hypertrophy, hypertelorism-preauricular sinus-punctual pits-deafness syndrome, craniofacial anomalies and anterior segment dysgenesis syndrome, microcephaly-capillary malformation syndrome, arthrogryposis, Perthes disease, and upward gaze palsy, platelet-activating factor acetylhydrolase deficiency, tetrasomy 18p, EDICT syndrome, cognitive impairment with or without cerebellar ataxia, peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome, glucocorticoid therapy, response to, transient infantile hypertriglyceridemia and hepatosteatosis, Huppke-Brendel syndrome, psychomotor retardation, epilepsy, and craniofacial dysmorphism, encephalomyopathy, mitochondrial, due to voltage-dependent anion channel deficiency, intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency, hypertelorism and other facial dysmorphism, brachydactyly, genital abnormalities, intellectual disability, and recurrent inflammatory episodes, alar cleft, isolated, facial paresis, hereditary congenital, 3, Malan overgrowth syndrome, metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria, immunodeficiency 28, retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome, phosphohydroxylysinuria, facial dysmorphism-immunodeficiency-livedo-short stature syndrome, intellectual disability-strabismus syndrome, estrogen resistance syndrome, severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, severe dermatitis-multiple allergies-metabolic wasting syndrome, severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome, testicular anomalies with or without congenital heart disease, multiple fibroadenoma of the breast, complement factor b deficiency, microcephaly-thin corpus callosum-intellectual disability syndrome, L-ferritin deficiency, macrocephaly-developmental delay syndrome, autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity, chromosome 16 inversion, 0.45-Mb, short stature due to GHSR deficiency, Webb-Dattani syndrome, kallikrein, decreased urinary activity of, short stature due to primary acid-labile subunit deficiency, hyperthyroxinemia, familial dysalbuminemic, congenital analbuminemia, immunodeficiency 37, retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome, chronic atrial and intestinal dysrhythmia, hyperproinsulinemia, Tenorio syndrome, congenital contractures of the limbs and face, hypotonia, and developmental delay, mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency, peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome, immunodeficiency 39, mandibulofacial dysostosis with alopecia, congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome, BENTA disease, microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, progressive microcephaly-seizures-cortical blindness-developmental delay syndrome, primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection, PMP22-RAI1 contiguous gene duplication syndrome, DeSanto-Shinawi syndrome due to WAC point mutation, familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome, palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome, wooly hair, autosomal recessive 3, leukodystrophy and acquired microcephaly with or without dystonia;, inherited oocyte maturation defect, Lamb-Shaffer syndrome, Luscan-Lumish syndrome, exercise intolerance, riboflavin-responsive, split-foot malformation-mesoaxial polydactyly syndrome, heart and brain malformation syndrome, chorea, childhood-onset, with psychomotor retardation, retinitis pigmentosa and erythrocytic microcytosis, macrocephaly, dysmorphic facies, and psychomotor retardation, MIRAGE syndrome, tall stature-intellectual disability-renal anomalies syndrome, Alazami-Yuan syndrome, ZTTK syndrome, Sifrim-Hitz-Weiss syndrome, short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay, Chitayat syndrome, language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia, Shashi-Pena syndrome, sudden cardiac failure, infantile, sudden cardiac failure, alcohol-induced, cone-rod dystrophy and hearing loss, lung disease, immunodeficiency, and chromosome breakage syndrome;, uncombable hair syndrome 2, uncombable hair syndrome 3, global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies, coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness, Yao syndrome, hypotonia, ataxia, and delayed development syndrome, FRAXF syndrome, aniridia - intellectual disability syndrome, radial deficiency-tibial hypoplasia syndrome, familial pancreatic carcinoma, progeroid syndrome, 17q11.2 microduplication syndrome, hereditary sensory and autonomic neuropathy with deafness and global delay, hereditary neoplastic syndrome, orofaciodigital syndrome, lethal recessive chondrodysplasia, Coffin-Siris syndrome, craniosynostosis, keratoconus, congenital pseudoarthrosis of the limbs, hereditary hemophagocytic lymphohistiocytosis, hereditary dementia, advanced sleep phase syndrome, dysmorphism-cleft palate-loose skin syndrome, oculomaxillofacial dysostosis, isolated congenital breast hypoplasia/aplasia, primary pigmented nodular adrenocortical disease, shoulder and thorax deformity-congenital heart disease syndrome, erythromelalgia, Cornelia de Lange syndrome, familial clubfoot with or without associated lower limb anomalies, hereditary gingival fibromatosis, syndromic microphthalmia, progressive non-infectious anterior vertebral fusion, hereditary hypoparathyroidism, hereditary hyperparathyroidism, familial ovarian cancer, hereditary breast carcinoma, heart-hand syndrome, Kabuki syndrome, familial hyperaldosteronism, lymphoproliferative syndrome, split hand-foot malformation, dysraphism-cleft lip/palate-limb reduction defects syndrome, primary hypertrophic osteoarthropathy, Melhem-Fahl syndrome, hereditary anemia, limb transversal defect-cardiac anomaly syndrome, frontonasal dysplasia, familial visceral myopathy, osteochondrodysplatic nanism-deafness-retinitis pigmentosa syndrome, Opitz G/BBB syndrome, oromandibular-limb hypogenesis syndrome, heritable pulmonary arterial hypertension, imperforate oropharynx-costo vetebral anomalies syndrome, familial vesicoureteral reflux, Pilotto syndrome, celiac trunk compression syndrome, 3MC syndrome, hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome, renal-hepatic-pancreatic dysplasia, lethal congenital contracture syndrome, triphalangeal thumb-polysyndactyly syndrome, autosomal recessive leukoencephalopathy-ischemic stroke-retinitis pigmentosa syndrome, van Maldergem syndrome, sclerosteosis, diencephalic-mesencephalic junction dysplasia, familial nonmedullary thyroid carcinoma, multiple synostoses syndrome, T-cell immunodeficiency with epidermodysplasia verruciformis, syngnathia multiple anomalies, syngnathia-cleft palate syndrome, humero-radio-ulnar synostosis, severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency, spondylocostal dysostosis-hypospadias-intellectual disability syndrome, thrombocytopenia-Robin sequence syndrome, tibial aplasia-ectrodactyly syndrome, microcephaly-brachydactyly-kyphoscoliosis syndrome, hereditary glaucoma, familial cervical artery dissection, bipartite talus, skeletal dysplasia, acrofacial dysostosis, chronic granulomatous disease, Hirschsprung disease, growth retardation-mild developmental delay-chronic hepatitis syndrome, osteonecrosis of genetic origin, global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome, hereditary gastric cancer, severe congenital neutropenia, hypogonadotropic hypogonadism, GCGR-related hyperglucagonemia, autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome, visceral heterotaxy, hereditary neuroendocrine tumor of small intestine, hereditary otorhinolaryngologic disease, congenital bilateral absence of vas deferens, bile duct cyst, Caroli syndrome, isolated neonatal sclerosing cholangitis, arterial calcification of infancy, branchiootic syndrome, Mazabraud syndrome, familial melanoma, inherited hemoglobinopathy, inborn errors of metabolism, familial thrombocytosis, androgen insensitivity syndrome, central precocious puberty, familial long QT syndrome, inherited obesity, Axenfeld-Rieger syndrome, inherited isolated nail anomaly, lymphatic malformation, ischio-vertebral syndrome, fetal and neonatal alloimmune thrombocytopenia, anterior segment dysgenesis, amelogenesis imperfecta, van der Woude syndrome, familial thoracic aortic aneurysm and aortic dissection, inherited primary ovarian failure, distal arthrogryposis, Ehlers-Danlos syndrome, inherited sideroblastic anemia, posterior polymorphous corneal dystrophy, familial parathyroid adenoma, Simpson-Golabi-Behmel syndrome type 1, sex-linked disease, microcephaly, growth restriction and increased sister chromatid exchange, microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome, autosomal dominant wooly hair, congenital short bowel syndrome, autosomal recessive, uncombable hair syndrome 1, Menke-Hennekam syndrome, dwarfism with tall vertebrae, pulmonary alveolar proteinosis with hypogammaglobulinemia, contractures, pterygia, and variable skeletal fusions syndrome, syndactyly, polydactyly, brachydactyly, RASopathy, immunodeficiency disease, laminopathy, inherited blood coagulation disorder, central centrifugal cicatricial alopecia, double fingernail of fifth finger, FRAXD syndrome, familial colorectal cancer, familial partial paralysis, Dursun syndrome, hereditary disorder of connective tissue, Marinesco-Sjogren-like syndrome, WHIM syndrome, visceral neuropathy, familial, neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset, portal hypertension, noncirrhotic, multiple congenital anomalies-neurodevelopmental syndrome, X-linked, azoospermia, obstructive, with nephrolithiasis, megacystis-microcolon-intestinal hypoperistalsis syndrome, Mullegama-Klein-Martinez syndrome, Shukla-Vernon syndrome, Basilicata-Akhtar syndrome, serpinopathy, peripheral neuropathy, autosomal recessive, with or without impaired intellectual development, intellectual developmental disorder with hypertelorism and distinctive facies, Diets-Jongmans syndrome, autoinflammation with episodic fever and lymphadenopathy, retinal dystrophy with leukodystrophy, skeletal dysplasia, mild, with joint laxity and advanced bone age, Nizon-Isidor syndrome, seizures, early-onset, with neurodegeneration and brain calcifications, leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome, leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome, proteinuria, chronic benign, Liberfarb syndrome, microcephaly, developmental delay, and brittle hair syndrome, 46,xx sex reversal 5, intellectual developmental disorder with autistic features and language delay, with or without seizures, neurodevelopmental, jaw, eye, and digital syndrome, agenesis of corpus callosum, cardiac, ocular, and genital syndrome, retinitis pigmentosa 89, spondylometaphyseal dysplasia with corneal dystrophy, Teebi hypertelorism syndrome, leukoencephalopathy, hereditary diffuse, with spheroids, gastrointestinal defect and immunodeficiency syndrome, developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy, intellectual developmental disorder with speech delay and axonal peripheral neuropathy, vertebral hypersegmentation and orofacial anomalies, cardiofacioneurodevelopmental syndrome, Kaya-Barakat-Masson syndrome, leukoencephalopathy, progressive, infantile-onset, with or without deafness, Lessel-Kreienkamp syndrome, intellectual developmental disorder with paroxysmal dyskinesia or seizures, Li-Campeau syndrome, neurofacioskeletal syndrome with or without renal agenesis, deafness, congenital, and adult-onset progressive leukoencephalopathy, oculomotor-abducens synkinesis, blistering, acantholytic, of oral and laryngeal mucosa, vertebral, cardiac, tracheoesophageal, renal, and limb defects, developmental delay with dysmorphic facies and dental anomalies, Kohlschutter-Tonz syndrome-like, bile acid conjugation defect 1, short stature, oligodontia, dysmorphic facies, and motor delay, global developmental delay with speech and behavioral abnormalities, vitreoretinopathy with phalangeal epiphyseal dysplasia, Baralle-Macken syndrome, dyskinesia with orofacial involvement, inherited interstitial lung disease, Bryant-Li-Bhoj neurodevelopmental syndrome, restrictive dermopathy, Stuve-Wiedemann syndrome, cardiac valvular defect, craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development syndrome, cardioacrofacial dysplasia, Tessadori-Van-Haaften neurodevelopmental syndrome, Carey-Fineman-Ziter syndrome, thyroid hormone metabolism, abnormal, short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies, developmental delay with short stature, dysmorphic facial features, and sparse hair, Braddock-Carey syndrome, ophthalmoplegia, external, with rib and vertebral anomalies, intellectual developmental disorder with macrocephaly, seizures, and speech delay, cardiac, facial, and digital anomalies with developmental delay, osteochondrodysplasia, brachydactyly, and overlapping malformed digits, warburg-cinotti syndrome, Snijders Blok-Campeau syndrome, inflammatory bowel disease, immunodeficiency, and encephalopathy, vertebral anomalies and variable endocrine and T-cell dysfunction, arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development, trichohepatoneurodevelopmental syndrome, mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations, fibrosis, neurodegeneration, and cerebral angiomatosis, cardiac-urogenital syndrome, visual impairment and progressive phthisis bulbi, microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum, macrocephaly, acquired, with impaired intellectual development, mucocutaneous ulceration, chronic, intellectual developmental disorder with cardiac defects and dysmorphic facies, global developmental delay with or without impaired intellectual development, infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development, intellectual developmental disorder with abnormal behavior, microcephaly, and short stature, polymicrogyria with or without vascular-type Ehlers-Danlos syndrome, microcephaly, growth deficiency, seizures, and brain malformations, short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis, turnpenny-fry syndrome, facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome, leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate, global developmental delay, progressive ataxia, and elevated glutamine, metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression, gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy, intellectual developmental disorder with short stature and variable skeletal anomalies, developmental delay with or without dysmorphic facies and autism, Khan-Khan-Katsanis syndrome, cerebellar, ocular, craniofacial, and genital syndrome, hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities, congenital hypotonia, epilepsy, developmental delay, and digital anomalies, cerebellar atrophy with seizures and variable developmental delay, O’Donnell-Luria-Rodan syndrome, ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features, hypopigmentation, organomegaly, and delayed myelination and development, glycosylphosphatidylinositol biosynthesis defect 21, spastic tetraplegia and axial hypotonia, progressive, snijders blok-fisher syndrome, intellectual developmental disorder with nasal speech, dysmorphic facies, and variable skeletal anomalies, lower urinary tract obstruction, congenital, Usher syndrome, type 1M, Siddiqi syndrome, oculopharyngeal myopathy with leukoencephalopathy 1, neurooculocardiogenitourinary syndrome, intellectual developmental disorder with impaired language and dysmorphic facies, hydrocephalus, congenital communicating, 1, intellectual developmental disorder with speech delay, autism, and dysmorphic facies, lessel-kubisch syndrome, intellectual developmental disorder with short stature and behavioral abnormalities, short stature and microcephaly with genital anomalies, megabladder, congenital, Heyn-Sproul-Jackson syndrome, intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures, ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies, Liang-Wang syndrome, neuromuscular disease and ocular or auditory anomalies with or without seizures, structural brain anomalies with impaired intellectual development and craniosynostosis, pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures, intellectual developmental disorder with hypotonia and behavioral abnormalities, Catifa syndrome, CEBALID syndrome, congenital heart defects, multiple types, 7, Imagawa-Matsumoto syndrome, juvenile arthritis due to defect in LACC1, Beck-Fahrner syndrome, respiratory papillomatosis, juvenile recurrent, congenital, sandestig-stefanova syndrome, triokinase and FMN cyclase deficiency syndrome, T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant, intellectual developmental disorder with poor growth and with or without seizures or ataxia, pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal, chromosome 1p36.33 duplication syndrome, atad3 gene cluster, autosomal dominant, genitourinary and/or brain malformation syndrome, rhizomelic limb shortening with dysmorphic features, Suleiman-El-Hattab syndrome, cone-rod synaptic disorder syndrome, congenital nonprogressive, Tolchin-Le Caignec syndrome, Li-Ghorbani-Weisz-Hubshman syndrome, autoinflammation, immune dysregulation, and eosinophilia, intellectual developmental disorder with seizures and language delay, mitochondrial complex 1 deficiency, nuclear type 35, deeah syndrome, combined oxidative phosphorylation deficiency 49, combined oxidative phosphorylation deficiency 50, Vissers-Bodmer syndrome, spinal muscular atrophy, infantile, James type, vitamin D-dependent rickets, type 3, cleft palate, proliferative retinopathy, and developmental delay, microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 1, congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome, microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome, early-onset familial hypoaldosteronism, chronic mast cell leukemia, DONSON-related microcephaly-short stature-limb abnormalities spectrum, choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome, CCNK-related neurodevelopmental disorder-severe intellectual disability-facial dysmorphism syndrome, cerebellar hypoplasia-intellectual disability-congenital microcephaly-dystonia-anemia-growth retardation syndrome, KLHL7-related Bohring-Opitz-like syndrome, oculogastrointestinal-neurodevelopmental syndrome, spastic paraparesis-cataracts-speech delay syndrome, inherited auditory system disease, Y chromosome infertility due to DAZ1 deletion, familial osteosclerosis, foveal hypoplasia, congenital heart defects, dysmorphic facial features, and intellectual developmental disorder, congenital heart defects and ectodermal dysplasia, brachycephaly, trichomegaly, and developmental delay, thrombocytopenia, anemia, and myelofibrosis, structural heart defects and renal anomalies syndrome, Rahman syndrome, retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome, familial monosomy 7 syndrome, menstrual cycle-dependent periodic fever, Gabriele de Vries syndrome, Lopes-Maciel-Rodan syndrome, Skraban-Deardorff syndrome, amyotonia congenita, cerebral sclerosis, diffuse, scholz type, autoinflammation with arthritis and dyskeratosis, retinal dystrophy with or without macular staphyloma, Cohen-Gibson syndrome, maleylacetoacetate isomerase deficiency, congenital heart defects and skeletal malformations syndrome, microcephaly, short stature, and limb abnormalities, congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay, cerebellar atrophy, developmental delay, and seizures, platelet abnormalities with eosinophilia and immune-mediated inflammatory disease, facial palsy, congenital, with ptosis and velopharyngeal dysfunction, immunodeficiency, developmental delay, and hypohomocysteinemia, Sweeney-Cox syndrome, combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia, Alkuraya-Kucinskas syndrome, Diamond-Blackfan anemia-like, hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome, chromosome 1p35 deletion syndrome, hyperthyroxinemia, euthyroid, caused by generalized 5-prime-deiodinase deficiency, Jaberi-Elahi syndrome, deafness, congenital heart defects, and posterior embryotoxon, humerofemoral hypoplasia with radiotibial ray deficiency, intellectual developmental disorder with or without epilepsy or cerebellar ataxia, CDKL5 disorder, GATA1-Related X-Linked Cytopenia, focal segmental glomerulosclerosis and neurodevelopmental syndrome, hereditary skin disorder, AP-4 deficiency syndrome, inherited kidney disorder, Mendelian encephalopathy, X inactivation, familial skewed, growth hormone insensitivity syndrome with immune dysregulation, DICER1-related tumor predisposition, A20 haploinsufficiency, LTBP2-related ocular dysgenesis, inherited cutis laxa, inherited hypertrophic pyloric stenosis, inherited thrombocytopenia, multiple congenital anomalies-hypotonia-seizures syndrome, 46,XX sex reversal 1, microcephaly, epilepsy, and diabetes syndrome, SEC61A1 deficiency, achalasia, familial esophageal, MECOM-associated syndrome, TPM4-related platelet disorder, TRAF3 haploinsufficiency, NKX2-1 related choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction, hereditary neurological disease, cardiogenetic disease, hereditary narcolepsy, RNU4ATAC spectrum disorder, CTNNB1-related neurodevelopmental disorder and/or vitreoretinopathy, MTOR-related overgrowth spectrum, TOR1AIP1-related nuclear envelopathy, BMP4-related ocular growth disorder, CSF1R-related disorder, acinar dysplasia caused by mutation in FGF10, acinar dysplasia caused by mutation in FGFR2, acinar dysplasia caused by mutation in TBX4, EPHB4-associated vascular malformation spectrum, BAFopathy, hereditary skeletal muscle disorder, hereditary gallbladder disorder, prostate cancer, hereditary, POLR3A-related disorder, POLR3B-related disorder, POLR1C-related disorder, WFS1-related disorder, CACNA1C-related disorder, SMAD6-related disease, central hypoventilation syndrome, congenital, autoinflammatory-pancytopenia syndrome due to DNASE2 deficiency, alopecia universalis, microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 2, myopathy, congenital, with excess of muscle spindles, pregnancy loss, recurrent, 4, urogenital adysplasia, yakut short stature syndrome, microcephaly, short stature, and impaired glucose metabolism, NR2F2 related multiple congenital anomalies/dysmorphic syndrome, ACD-related telomere biology disorder, AKT3-related overgrowth spectrum, rhabdomyosarcoma, embryonal, 2, blepharophimosis-impaired intellectual development syndrome, Radio-Tartaglia syndrome, Buratti-Harel syndrome, growth restriction, hypoplastic kidneys, alopecia, and distinctive facies, fibromuscular dysplasia, multifocal, dysostosis multiplex, Ain-Naz type, ataxia, intention tremor, and hypotonia syndrome, childhood-onset, deafness, cataract, impaired intellectual development, and polyneuropathy, onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome, Faundes-Banka syndrome, osteootohepatoenteric syndrome, hypokalemic tubulopathy and deafness, White-Kernohan syndrome, retinal dystrophy and microvillus inclusion disease, Luo-Schoch-Yamamoto syndrome, Usmani-Riazuddin syndrome, autosomal dominant, VISS syndrome, developmental delay, impaired speech, and behavioral abnormalities, bile acid malabsorption, primary, 2, DEGCAGS syndrome, Short stature, Dauber-Argente type, ventriculomegaly and arthrogryposis, Chopra-Amiel-Gordon syndrome, muscular dystrophy, congenital hearing loss, and ovarian insufficiency syndrome, neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities, biliary, renal, neurologic, and skeletal syndrome, Boudin-Mortier syndrome, Usmani-Riazuddin syndrome, autosomal recessive, intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies, short stature, impaired intellectual development, microcephaly, hypotonia, and ocular anomalies, developmental delay with or without intellectual impairment or behavioral abnormalities, cerebellar ataxia, brain abnormalities, and cardiac conduction defects, developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities, fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies, delayed puberty, self-limited, Hengel-Maroofian-Schols syndrome, Zaki syndrome, dystonia, early-onset, and/or spastic paraplegia, developmental delay with variable neurologic and brain abnormalities, Rauch-Steindl syndrome, intellectual disability and myopathy syndrome, cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism, Kury-Isidor syndrome, macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin, intellectual developmental disorder with or without peripheral neuropathy, neurocardiofaciodigital syndrome, corneal dystrophy, punctiform and polychromatic pre-descemet, osteoporosis, childhood- or juvenile-onset, with developmental delay, hepatorenocardiac degenerative fibrosis, ACCES syndrome, developmental delay, impaired speech, and behavioral abnormalities, with or without seizures, liver disease, severe congenital, primordial dwarfism-immunodeficiency-lipodystrophy syndrome, intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects, keratoderma-ichthyosis-deafness syndrome, autosomal recessive, developmental delay, hypotonia, and impaired language, intellectual developmental disorder with autism and dysmorphic facies, bone marrow failure and diabetes mellitus syndrome, developmental delay, behavioral abnormalities, and neuropsychiatric disorders, hypermetabolism due to uncoupled mitochondrial oxidative phosphorylation 2, intellectual developmental disorder with ocular anomalies and distinctive facial features, developmental delay with variable intellectual disability and dysmorphic facies, myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis 1, developmental delay, language impairment, and ocular abnormalities, Rabin-Pappas syndrome, muscular dystrophy, congenital, with or without seizures, obesity and hypopigmentation, joint contractures, osteochondromas, and B-cell lymphoma, respiratory infections, recurrent, and failure to thrive with or without diarrhea, developmental delay with hypotonia, myopathy, and brain abnormalities, Atelis syndrome, hereditary neuro-ophthalmological disease, autoinflammation with pulmonary and cutaneous vasculitis, neurooculorenal syndrome, combined low LDL and fibrinogen, hypersulfaturia, woolly hair-skin fragility syndrome, hematuria, benign familial, cataracts, hearing impairment, nephrotic syndrome, and enterocolitis, disabling pansclerotic morphea of childhood, Houge-Janssens syndrome, hearing loss, noise-induced, susceptibility to, encephalitis, acute, infection-induced, susceptibility to, 12, cranial dysinnervation disorder, congenital, with absent corneal reflex and developmental delay, congenital smooth muscle hamartoma, with or without hemihypertrophy, amegakaryocytic thrombocytopenia, congenital, 2, epilepsy, early-onset, xerosis and growth failure with immune and pulmonary dysfunction syndrome, Fliedner-Zweier syndrome, immune dysregulation, autoimmunity, and autoinflammation, arrhythmogenic cardiomyopathy with variable ectodermal abnormalities, developmental delay, dysmorphic facies, and brain anomalies, developmental delay with or without epilepsy, craniometadiaphyseal osteosclerosis with hip dysplasia, Lui-Jee-Baron syndrome, Long-Olsen-Distelmaier syndrome, Tan-Almurshedi syndrome, diabetes, deafness, developmental delay, and short stature syndrome, Alfadhel syndrome, Hoxha-Aliu syndrome, congenital insensitivity to pain syndrome, Marsili type, Yuksel-Vogel-Bauer syndrome, polydactyly-macrocephaly syndrome, isolated hyperferritinemia, megalencephaly-polydactyly syndrome, autoinflammation with episodic fever and immune dysregulation, autoinflammation with arthritis and vasculitis, myelofibrosis, congenital, with anemia, neutropenia, developmental delay, and ocular abnormalities, brain malformation renal syndrome, short stature with nonspecific skeletal abnormalities, bronchiectasis and nasal polyposis, neurodegeneration, infantile-onset, with optic atrophy and brain abnormalities, spastic paraplegia, mitochondrial, Pan-Chung-Bellen syndrome, autoinflammation, panniculitis, and dermatosis syndrome, telangiectasia, impaired intellectual development, microcephaly, metaphyseal dysplasia, eye abnormalities, and short stature, Muggenthaler-Chowdhury-Chioza syndrome, ocular pterygium-digital keloid dysplasia syndrome, Tayoun-Maawali syndrome, craniofaciocardiohepatic syndrome, FICUS syndrome, Guillouet-Gordon syndrome, immunodysregulation with variable immunodeficiency and autoimmunity, ICHAD syndrome, cataract, alopecia, oral mucosal disorder, and psoriasis-like syndrome, immune dysregulation with immunodeficiency due to AIOLOS haploinsufficiency, ADNP-related blepharophimosis-intellectual disability syndrome, oculovertebral syndrome, Ververi-Brady syndrome, immune dysregulation, neurodevelopmental defects, and colitis, dyschromatosis, ichthyosis, deafness, and atopic disease, developmental delay with variable cardiac and renal congenital anomalies and dysmorphic facies, developmental delay with sleep apnea, Pitt-Hopkins or Pitt-Hopkins-like syndrome, intellectual developmental disorder, autosomal recessive 84, intellectual developmental disorder, autosomal dominant 77, periodontitis, aggressive, dental radicular dysplasia, intellectual developmental disorder with seizures and dysmorphic facies, STAD syndrome, craniosynostosis-scoliosis syndrome, COL4A1/A2-related disorder, TP63-related ectodermal dysplasia spectrum with limb and orofacial malformations, PI4KA-related disorder, NDUFB11-related disorders, EN1-related dorsoventral syndrome, DHDDS-CDG, PLEC-related muscular dystrophy-epidermolysis bullosa simplex spectrum disorder, FDXR-related optic atrophy mitochondrial dysfunction syndrome, PIK3R1-related immunodeficiency and SHORT syndrome, ACAN-related short stature spectrum, ELANE-related neutropenia, NR5A1-related sex development disorder, CRYAB-related myofibrillar myopathy-cataract-cardiomyopathy spectrum disorder, SYCE1-related gametogenic failure, RNU12-related minor spliceopathy disorder, MCM9-related gametogenic failure, CFTR-related disorder
Subtypes (24): prenatal-onset spinal muscular atrophy with congenital bone fractures, adducted thumbs-arthrogryposis syndrome, Christian type, arthrogryposis multiplex congenita 2, neurogenic type, fetal akinesia deformation sequence, arthrogryposis multiplex congenita-whistling face syndrome, arthrogryposis-hyperkeratosis syndrome, lethal form, multiple pterygium-malignant hyperthermia syndrome, Marden-Walker syndrome, arthrogryposis due to muscular dystrophy, infantile-onset X-linked spinal muscular atrophy, van den Ende-Gupta syndrome, lethal arthrogryposis-anterior horn cell disease syndrome, lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome, arthrogryposis-like syndrome, autosomal recessive myogenic arthrogryposis multiplex congenita, Wieacker-Wolff syndrome (spectrum), arthrogryposis multiplex congenita 6, arthrogryposis multiplex congenita 3, myogenic type, arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum, microphthalmia microtia fetal akinesia, MYBPC1-related autosomal recessive non-lethal arthrogryposis multiplex congenita syndrome, arthrogryposis multiplex congenita 5, hypomyelination neuropathy-arthrogryposis syndrome, arthrogryposis multiplex congenita 7, X-linked
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
ClinVar germline variants
102 retrieved; paginated sample, class counts are floors:
28 uncertain significance, 23 conflicting classifications of pathogenicity, 22 likely pathogenic, 12 pathogenic, 8 pathogenic/likely pathogenic, 6 likely benign, 3 benign
| ClinVar | Variant (HGVS) | Gene | Classification | Review |
|---|---|---|---|---|
| 692271 | NM_001100.4(ACTA1):c.739G>A (p.Gly247Arg) | ACTA1 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 192347 | NM_198569.3(ADGRG6):c.19C>T (p.Arg7Ter) | ADGRG6 | Pathogenic | criteria provided, single submitter |
| 192348 | NM_198569.3(ADGRG6):c.2144dup (p.Gln716fs) | ADGRG6 | Pathogenic | criteria provided, single submitter |
| 192349 | NM_198569.3(ADGRG6):c.2306T>A (p.Val769Glu) | ADGRG6 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 692295 | NM_152328.5(ADSS1):c.741del (p.Lys248fs) | ADSS1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 619021 | NM_001198800.3(ASCC1):c.626+1G>A | ASCC1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 280518 | NM_018136.5(ASPM):c.3082+1G>C | ASPM | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 692298 | NM_018136.5(ASPM):c.2863C>T (p.Gln955Ter) | ASPM | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 422408 | NM_001003800.2(BICD2):c.1636_1638del (p.Asn546del) | BICD2 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 692274 | NM_003632.3(CNTNAP1):c.69C>G (p.Tyr23Ter) | CNTNAP1 | Pathogenic | criteria provided, single submitter |
| 1012274 | NC_000005.9:g.172252136_172274628del | ERGIC1 | Pathogenic | criteria provided, single submitter |
| 452116 | NM_181789.4(GLDN):c.1428C>A (p.Phe476Leu) | GLDN | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 631486 | NM_002478.5(MYOD1):c.557dup (p.Arg188fs) | MYOD1 | Pathogenic | criteria provided, single submitter |
| 137629 | NM_001378183.1(PIEZO2):c.8396G>A (p.Arg2799His) | PIEZO2 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 632546 | NM_001378183.1(PIEZO2):c.1384C>T (p.Arg462Ter) | PIEZO2 | Pathogenic | criteria provided, single submitter |
| 433177 | NM_000540.3(RYR1):c.10620C>G (p.Tyr3540Ter) | RYR1 | Pathogenic | criteria provided, single submitter |
| 692285 | NM_000540.3(RYR1):c.14647-15_14649del | RYR1 | Pathogenic | criteria provided, single submitter |
| 692286 | NM_000540.3(RYR1):c.2500_2501dup (p.Pro836fs) | RYR1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 692288 | NM_000540.3(RYR1):c.5618del (p.Glu1873fs) | RYR1 | Pathogenic | criteria provided, single submitter |
| 1031 | NM_015559.3(SETBP1):c.2612T>C (p.Ile871Thr) | SETBP1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 692306 | NM_001080.3(ALDH5A1):c.814del (p.Cys272fs) | ALDH5A1 | Likely pathogenic | criteria provided, single submitter |
| 692299 | NM_001001344.3(ATP2B3):c.197C>T (p.Ser66Leu) | ATP2B3 | Likely pathogenic | criteria provided, single submitter |
| 692318 | NM_001384125.1(BLTP1):c.3926G>A (p.Arg1309Gln) | BLTP1 | Likely pathogenic | criteria provided, single submitter |
| 692319 | NM_001384125.1(BLTP1):c.12154T>C (p.Tyr4052His) | BLTP1 | Likely pathogenic | criteria provided, single submitter |
| 978640 | NM_001384125.1(BLTP1):c.3323+1G>A | BLTP1 | Likely pathogenic | criteria provided, single submitter |
| 978675 | NM_001384125.1(BLTP1):c.692del (p.Phe231fs) | BLTP1 | Likely pathogenic | criteria provided, single submitter |
| 692273 | NM_000751.3(CHRND):c.452G>C (p.Cys151Ser) | CHRND | Likely pathogenic | criteria provided, single submitter |
| 692272 | NM_005199.5(CHRNG):c.710_711delinsAA (p.Ile237Lys) | CHRNG | Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 692275 | NM_003632.3(CNTNAP1):c.1906G>A (p.Val636Met) | CNTNAP1 | Likely pathogenic | criteria provided, single submitter |
| 4056089 | NM_198721.4(COL25A1):c.836G>C (p.Gly279Ala) | COL25A1 | Likely pathogenic | criteria provided, single submitter |
Genes & proteins
Mendelian disease overlap and somatic drivers
GenCC: 13 · Orphanet: 120 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0
GenCC gene–disease validity (cohort genes)
the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.
| Gene | Classification | Inheritance | Disease | Records |
|---|---|---|---|---|
| SENP7 | Strong | Autosomal recessive | arthrogryposis multiplex congenita | |
| KIF21A | Moderate | Autosomal recessive | arthrogryposis multiplex congenita | 9 |
| UNC50 | Moderate | Autosomal recessive | arthrogryposis multiplex congenita | 2 |
| VPS8 | Limited | Unknown | arthrogryposis multiplex congenita |
Orphanet rare-disease linkage (cohort genes)
| Gene | Orphanet ID | Rare disease |
|---|---|---|
| KIF21A | Orphanet:45358 | Congenital fibrosis of extraocular muscles |
| KIF21A | Orphanet:994 | Fetal akinesia deformation sequence |
| ROR2 | Orphanet:1507 | Autosomal recessive Robinow syndrome |
| ROR2 | Orphanet:572385 | Brachydactyly type B1 |
| RYR1 | Orphanet:169186 | Autosomal recessive centronuclear myopathy |
| RYR1 | Orphanet:169189 | Autosomal dominant centronuclear myopathy |
| RYR1 | Orphanet:178145 | Moderate multiminicore disease with hand involvement |
| RYR1 | Orphanet:324581 | Benign Samaritan congenital myopathy |
| RYR1 | Orphanet:33108 | Lethal multiple pterygium syndrome |
| RYR1 | Orphanet:423 | Malignant hyperthermia of anesthesia |
| RYR1 | Orphanet:424107 | Congenital myopathy with myasthenic-like onset |
| RYR1 | Orphanet:466650 | Exercise-induced malignant hyperthermia |
| RYR1 | Orphanet:597 | Central core disease |
| RYR1 | Orphanet:700188 | Calf-predominant weakness-gastrocnemius medialis atrophy-distal myopathy |
| RYR1 | Orphanet:98905 | Congenital multicore myopathy with external ophthalmoplegia |
| RYR1 | Orphanet:99741 | King-Denborough syndrome |
| SCN4A | Orphanet:681 | Hypokalemic periodic paralysis |
| SCN4A | Orphanet:682 | Hyperkalemic periodic paralysis |
| SCN4A | Orphanet:684 | Paramyotonia congenita of Von Eulenburg |
| SCN4A | Orphanet:98913 | Postsynaptic congenital myasthenic syndrome |
| SCN4A | Orphanet:99734 | Myotonia fluctuans |
| SCN4A | Orphanet:99735 | Myotonia permanens |
| SCN4A | Orphanet:99736 | Acetazolamide-responsive myotonia |
| SCN5A | Orphanet:101016 | Romano-Ward syndrome |
| SCN5A | Orphanet:130 | Brugada syndrome |
| SCN5A | Orphanet:1344 | Isolated atrial standstill |
| SCN5A | Orphanet:154 | Familial isolated dilated cardiomyopathy |
| SCN5A | Orphanet:166282 | Hereditary sick sinus syndrome |
| SCN5A | Orphanet:228140 | Idiopathic ventricular fibrillation |
| SCN5A | Orphanet:334 | Hereditary atrial fibrillation |
| SCN5A | Orphanet:871 | Hereditary progressive cardiac conduction defect |
| SCN8A | Orphanet:178469 | Autosomal dominant non-syndromic intellectual disability |
| SCN8A | Orphanet:306 | Self-limited infantile epilepsy |
| SCN8A | Orphanet:352582 | Familial infantile myoclonic epilepsy |
| SCN8A | Orphanet:442835 | Non-specific early-onset epileptic encephalopathy |
| SLC35A3 | Orphanet:370943 | Autism spectrum disorder-epilepsy-arthrogryposis syndrome |
| TMPO | Orphanet:154 | Familial isolated dilated cardiomyopathy |
| ACTA1 | Orphanet:171430 | Severe congenital nemaline myopathy |
| ACTA1 | Orphanet:171433 | Intermediate nemaline myopathy |
| ACTA1 | Orphanet:171436 | Typical nemaline myopathy |
| ACTA1 | Orphanet:171439 | Childhood-onset nemaline myopathy |
| ACTA1 | Orphanet:2020 | Congenital fiber-type disproportion myopathy |
| ACTA1 | Orphanet:447977 | Progressive scapulohumeroperoneal distal myopathy |
| ACTA1 | Orphanet:97240 | Zebra body myopathy |
| ACTA1 | Orphanet:97244 | Rigid spine syndrome |
| ACTA1 | Orphanet:98904 | Congenital myopathy with excess of thin filaments |
| ZEB2 | Orphanet:261537 | Mowat-Wilson syndrome due to monosomy 2q22 |
| ZEB2 | Orphanet:261552 | Mowat-Wilson syndrome due to a ZEB2 point mutation |
| ZEB2 | Orphanet:626 | Large/giant congenital melanocytic nevus |
| SETBP1 | Orphanet:436151 | Intellectual disability-expressive aphasia-facial dysmorphism syndrome |
Cohort genes → proteins
57 cohort genes, 57 distinct canonical proteins.
Evidence partition
| Subset | Genes |
|---|---|
| multi_evidence | 57 |
Cohort genes (full)
| Symbol | HGNC | Ensembl | UniProt | Name | Evidence |
|---|---|---|---|---|---|
| UNC50 | HGNC:16046 | ENSG00000115446 | Q53HI1 | Protein unc-50 homolog | gencc,clinvar |
| KIF21A | HGNC:19349 | ENSG00000139116 | Q7Z4S6 | Kinesin-like protein KIF21A | gencc |
| VPS8 | HGNC:29122 | ENSG00000156931 | Q8N3P4 | Vacuolar protein sorting-associated protein 8 homolog | gencc |
| SENP7 | HGNC:30402 | ENSG00000138468 | Q9BQF6 | Sentrin-specific protease 7 | gencc |
| ROR2 | HGNC:10257 | ENSG00000169071 | Q01974 | Tyrosine-protein kinase transmembrane receptor ROR2 | clinvar |
| RYR1 | HGNC:10483 | ENSG00000196218 | P21817 | Ryanodine receptor 1 | clinvar |
| SCN4A | HGNC:10591 | ENSG00000007314 | P35499 | Sodium channel protein type 4 subunit alpha | clinvar |
| SCN5A | HGNC:10593 | ENSG00000183873 | Q14524 | Sodium channel protein type 5 subunit alpha | clinvar |
| SCN8A | HGNC:10596 | ENSG00000196876 | Q9UQD0 | Sodium channel protein type 8 subunit alpha | clinvar |
| SLC35A3 | HGNC:11023 | ENSG00000117620 | Q9Y2D2 | UDP-N-acetylglucosamine transporter | clinvar |
| TMPO | HGNC:11875 | ENSG00000120802 | P42166 | Lamina-associated polypeptide 2, isoform alpha | clinvar |
| ACTA1 | HGNC:129 | ENSG00000143632 | P68133 | Actin, alpha skeletal muscle | clinvar |
| AVEN | HGNC:13509 | ENSG00000169857 | Q9NQS1 | Cell death regulator Aven | clinvar |
| GFRA4 | HGNC:13821 | ENSG00000125861 | Q9GZZ7 | GDNF family receptor alpha-4 | clinvar |
| ADGRG6 | HGNC:13841 | ENSG00000112414 | Q86SQ4 | Adhesion G-protein coupled receptor G6 | clinvar |
| ZEB2 | HGNC:14881 | ENSG00000169554 | O60315 | Zinc finger E-box-binding homeobox 2 | clinvar |
| SETBP1 | HGNC:15573 | ENSG00000152217 | Q9Y6X0 | SET-binding protein | clinvar |
| KIF1B | HGNC:16636 | ENSG00000054523 | O60333 | Kinesin-like protein KIF1B | clinvar |
| PRICKLE1 | HGNC:17019 | ENSG00000139174 | Q96MT3 | Prickle-like protein 1 | clinvar |
| BICD2 | HGNC:17208 | ENSG00000185963 | Q8TD16 | Protein bicaudal D homolog 2 | clinvar |
| COL25A1 | HGNC:18603 | ENSG00000188517 | Q9BXS0 | Collagen alpha-1(XXV) chain | clinvar |
| LGI4 | HGNC:18712 | ENSG00000153902 | Q8N135 | Leucine-rich repeat LGI family member 4 | clinvar |
| ASPM | HGNC:19048 | ENSG00000066279 | Q8IZT6 | Abnormal spindle-like microcephaly-associated protein | clinvar |
| NALCN | HGNC:19082 | ENSG00000102452 | Q8IZF0 | Sodium leak channel NALCN | clinvar |
| CHRND | HGNC:1965 | ENSG00000135902 | Q07001 | Acetylcholine receptor subunit delta | clinvar |
| CHRNG | HGNC:1967 | ENSG00000196811 | P07510 | Acetylcholine receptor subunit gamma | clinvar |
| ADSS1 | HGNC:20093 | ENSG00000185100 | Q8N142 | Adenylosuccinate synthetase isozyme 1 | clinvar |
| DQX1 | HGNC:20410 | ENSG00000144045 | Q8TE96 | ATP-dependent RNA helicase homolog DQX1 | clinvar |
| SPAG16 | HGNC:23225 | ENSG00000144451 | Q8N0X2 | Sperm-associated antigen 16 protein | clinvar |
| VPS13D | HGNC:23595 | ENSG00000048707 | Q5THJ4 | Intermembrane lipid transfer protein VPS13D | clinvar |
| ASCC1 | HGNC:24268 | ENSG00000138303 | Q8N9N2 | Activating signal cointegrator 1 complex subunit 1 | clinvar |
| PIEZO2 | HGNC:26270 | ENSG00000154864 | Q9H5I5 | Piezo-type mechanosensitive ion channel component 2 | clinvar |
| BLTP1 | HGNC:26953 | ENSG00000138688 | Q2LD37 | Bridge-like lipid transfer protein family member 1 | clinvar |
| IQSEC3 | HGNC:29193 | ENSG00000120645 | Q9UPP2 | IQ motif and SEC7 domain-containing protein 3 | clinvar |
| ERGIC1 | HGNC:29205 | ENSG00000113719 | Q969X5 | Endoplasmic reticulum-Golgi intermediate compartment protein 1 | clinvar |
| EARS2 | HGNC:29419 | ENSG00000103356 | Q5JPH6 | Nondiscriminating glutamyl-tRNA synthetase EARS2, mitochondrial | clinvar |
| SH3TC2 | HGNC:29427 | ENSG00000169247 | Q8TF17 | SH3 domain and tetratricopeptide repeat-containing protein 2 | clinvar |
| GLDN | HGNC:29514 | ENSG00000186417 | Q6ZMI3 | Gliomedin | clinvar |
| DYNC1H1 | HGNC:2961 | ENSG00000197102 | Q14204 | Cytoplasmic dynein 1 heavy chain 1 | clinvar |
| MAGI3 | HGNC:29647 | ENSG00000081026 | Q5TCQ9 | Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 | clinvar |
| SEPSECS | HGNC:30605 | ENSG00000109618 | Q9HD40 | O-phosphoseryl-tRNA(Sec) selenium transferase | clinvar |
| ECEL1 | HGNC:3147 | ENSG00000171551 | O95672 | Endothelin-converting enzyme-like 1 | clinvar |
| F9 | HGNC:3551 | ENSG00000101981 | P00740 | Coagulation factor IX | clinvar |
| FBLN1 | HGNC:3600 | ENSG00000077942 | P23142 | Fibulin-1 | clinvar |
| FZD3 | HGNC:4041 | ENSG00000104290 | Q9NPG1 | Frizzled-3 | clinvar |
| ALDH5A1 | HGNC:408 | ENSG00000112294 | P51649 | Succinate-semialdehyde dehydrogenase, mitochondrial | clinvar |
| GBE1 | HGNC:4180 | ENSG00000114480 | Q04446 | 1,4-alpha-glucan-branching enzyme | clinvar |
| GCN1 | HGNC:4199 | ENSG00000089154 | Q92616 | Stalled ribosome sensor GCN1 | clinvar |
| ZNF875 | HGNC:4928 | ENSG00000181666 | P10072 | Zinc finger protein 875 | clinvar |
| ASAH1 | HGNC:735 | ENSG00000104763 | Q13510 | Acid ceramidase | clinvar |
Cohort function summary
Lead sentence per gene, UniProt-curated.
| Symbol | Protein name | Function (lead sentence) |
|---|---|---|
| UNC50 | Protein unc-50 homolog | Involved in the cell surface expression of neuronal nicotinic receptors. |
| KIF21A | Kinesin-like protein KIF21A | Processive microtubule plus-end directed motor protein involved in neuronal axon guidance. |
| VPS8 | Vacuolar protein sorting-associated protein 8 homolog | Plays a role in vesicle-mediated protein trafficking of the endocytic membrane transport pathway. |
| SENP7 | Sentrin-specific protease 7 | Protease that acts as a positive regulator of the cGAS-STING pathway by catalyzing desumoylation of CGAS. |
| ROR2 | Tyrosine-protein kinase transmembrane receptor ROR2 | Tyrosine-protein kinase receptor which may be involved in the early formation of the chondrocytes. |
| RYR1 | Ryanodine receptor 1 | Cytosolic calcium-activated calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytosol and thereby plays a key role in triggering muscle contraction following depolarization of T-tubules. |
| SCN4A | Sodium channel protein type 4 subunit alpha | Pore-forming subunit of Nav1.4, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. |
| SCN5A | Sodium channel protein type 5 subunit alpha | Pore-forming subunit of Nav1.5, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. |
| SCN8A | Sodium channel protein type 8 subunit alpha | Pore-forming subunit of a voltage-gated sodium channel complex assuming opened or closed conformations in response to the voltage difference across membranes and through which sodium ions selectively pass along their electrochemical gradie… |
| SLC35A3 | UDP-N-acetylglucosamine transporter | Transports diphosphate-N-acetylglucosamine (UDP-GlcNAc) from the cytosol into the lumen of the Golgi apparatus, functioning as an antiporter that exchanges UDP-N-acetyl-alpha-D-glucosamine for UMP. |
| TMPO | Lamina-associated polypeptide 2, isoform alpha | May be involved in the structural organization of the nucleus and in the post-mitotic nuclear assembly. |
| ACTA1 | Actin, alpha skeletal muscle | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. |
| AVEN | Cell death regulator Aven | Protects against apoptosis mediated by Apaf-1. |
| GFRA4 | GDNF family receptor alpha-4 | Receptor for persephin (PSPN), a growth factor that exhibits neurotrophic activity on mesencephalic dopaminergic and motor neurons. |
| ADGRG6 | Adhesion G-protein coupled receptor G6 | Adhesion G-protein coupled receptor (aGPCR) for steroid hormones, such as progesterone and 17alpha-hydroxyprogesterone (17OHP). |
| ZEB2 | Zinc finger E-box-binding homeobox 2 | Transcriptional inhibitor that binds to DNA sequence 5’-CACCT-3’ in different promoters. |
| KIF1B | Kinesin-like protein KIF1B | Has a plus-end-directed microtubule motor activity and functions as a motor for transport of vesicles and organelles along microtubules. |
| PRICKLE1 | Prickle-like protein 1 | Involved in the planar cell polarity pathway that controls convergent extension during gastrulation and neural tube closure. |
| BICD2 | Protein bicaudal D homolog 2 | Acts as an adapter protein linking the dynein motor complex to various cargos and converts dynein from a non-processive to a highly processive motor in the presence of dynactin. |
| COL25A1 | Collagen alpha-1(XXV) chain | Inhibits fibrillization of amyloid-beta peptide during the elongation phase. |
| LGI4 | Leucine-rich repeat LGI family member 4 | Component of Schwann cell signaling pathway(s) that controls axon segregation and myelin formation. |
| ASPM | Abnormal spindle-like microcephaly-associated protein | Involved in mitotic spindle regulation and coordination of mitotic processes. |
| NALCN | Sodium leak channel NALCN | Voltage-gated ion channel responsible for the resting Na(+) permeability that controls neuronal excitability. |
| CHRND | Acetylcholine receptor subunit delta | After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. |
| CHRNG | Acetylcholine receptor subunit gamma | After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. |
| ADSS1 | Adenylosuccinate synthetase isozyme 1 | Component of the purine nucleotide cycle (PNC), which interconverts IMP and AMP to regulate the nucleotide levels in various tissues, and which contributes to glycolysis and ammoniagenesis. |
| DQX1 | ATP-dependent RNA helicase homolog DQX1 | Might be involved in RNA metabolism; it is missing helicase motif III and may not have helicase activity. |
| SPAG16 | Sperm-associated antigen 16 protein | Necessary for sperm flagellar function. |
| VPS13D | Intermembrane lipid transfer protein VPS13D | Mediates the transfer of lipids between membranes at organelle contact sites. |
| ASCC1 | Activating signal cointegrator 1 complex subunit 1 | Plays a role in DNA damage repair as component of the ASCC complex. |
| PIEZO2 | Piezo-type mechanosensitive ion channel component 2 | Pore-forming subunit of the mechanosensitive non-specific cation Piezo channel required for rapidly adapting mechanically activated (MA) currents and has a key role in sensing touch and tactile pain. |
| BLTP1 | Bridge-like lipid transfer protein family member 1 | Bridge-like lipid transfer protein that functions as molecular bridges between endoplasmic reticulum and the membranes targeted for lipid delivery. |
| IQSEC3 | IQ motif and SEC7 domain-containing protein 3 | Acts as a guanine nucleotide exchange factor (GEF) for ARF1. |
| ERGIC1 | Endoplasmic reticulum-Golgi intermediate compartment protein 1 | Possible role in transport between endoplasmic reticulum and Golgi. |
| EARS2 | Nondiscriminating glutamyl-tRNA synthetase EARS2, mitochondrial | Non-discriminating glutamyl-tRNA synthetase that catalyzes aminoacylation of both mitochondrial tRNA(Glu) and tRNA(Gln) and participates in RNA aminoacylation for mitochondrial protein translation. |
| SH3TC2 | SH3 domain and tetratricopeptide repeat-containing protein 2 | Is involved in nerve myelination and is required for the integrity of nodes of Ranvier. |
| GLDN | Gliomedin | Ligand for NRCAM and NFASC/neurofascin that plays a role in the formation and maintenance of the nodes of Ranvier on myelinated axons. |
| DYNC1H1 | Cytoplasmic dynein 1 heavy chain 1 | Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. |
| MAGI3 | Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 | Acts as a scaffolding protein at cell-cell junctions, thereby regulating various cellular and signaling processes. |
| SEPSECS | O-phosphoseryl-tRNA(Sec) selenium transferase | Converts O-phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec) required for selenoprotein biosynthesis. |
| ECEL1 | Endothelin-converting enzyme-like 1 | May contribute to the degradation of peptide hormones and be involved in the inactivation of neuronal peptides. |
| F9 | Coagulation factor IX | Factor IX is a vitamin K-dependent plasma protein that participates in the intrinsic pathway of blood coagulation by converting factor X to its active form in the presence of Ca(2+) ions, phospholipids, and factor VIIIa. |
| FBLN1 | Fibulin-1 | Incorporated into fibronectin-containing matrix fibers. |
| FZD3 | Frizzled-3 | Receptor for Wnt proteins. |
| ALDH5A1 | Succinate-semialdehyde dehydrogenase, mitochondrial | Catalyzes one step in the degradation of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). |
| GBE1 | 1,4-alpha-glucan-branching enzyme | Glycogen-branching enzyme participates in the glycogen biosynthetic process along with glycogenin and glycogen synthase. |
| GCN1 | Stalled ribosome sensor GCN1 | Ribosome collision sensor that plays a key role in the RNF14-RNF25 translation quality control pathway, a pathway that takes place when a ribosome has stalled during translation, and which promotes ubiquitination and degradation of transla… |
| ZNF875 | Zinc finger protein 875 | May be involved in transcriptional regulation. |
| ASAH1 | Acid ceramidase | Lysosomal ceramidase that hydrolyzes sphingolipid ceramides into sphingosine and free fatty acids at acidic pH. |
| MYH3 | Myosin-3 | Muscle contraction. |
Protein-family classification
Druggable: 20 · Difficult: 12 · Unknown: 25 · Druggable fraction: 0.35
Family distribution
Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.
| Family | Genes | Fold | FDR |
|---|---|---|---|
| Ion channel | 5 | 9.8× | 0.002 |
| Complement | 1 | 4.7× | 0.582 |
| Protease | 3 | 1.9× | 0.582 |
| Scaffold/PPI | 5 | 1.5× | 0.582 |
| Enzyme (other) | 5 | 1.1× | 0.768 |
| Antibody/Immunoglobulin | 2 | 1.0× | 0.768 |
| Transcription factor | 7 | 1.0× | 0.768 |
| Kinase | 2 | 1.0× | 0.768 |
| GPCR | 2 | 0.8× | 0.771 |
| Other/Unknown | 25 | 0.8× | 0.974 |
Per-gene assignment
| Symbol | Family | Druggable? | EC | InterPro (top 3) |
|---|---|---|---|---|
| UNC50 | Other/Unknown | no | UNC-50 | |
| KIF21A | Scaffold/PPI | no | WD40_rpt, Kinesin_motor_dom, WD40/YVTN_repeat-like_dom_sf | |
| VPS8 | Transcription factor | no | WD40_rpt, Znf_RING, Quino_amine_DH_bsu | |
| SENP7 | Protease | yes | 3.4.22.B75 | Peptidase_C48_C, Papain-like_cys_pep_sf, Sentrin-specific_protease |
| ROR2 | Kinase | yes | 2.7.10.1 | Kringle, Prot_kinase_dom, Ser-Thr/Tyr_kinase_cat_dom |
| RYR1 | Ion channel | yes | RIH_dom, B30.2/SPRY, Ryanodine_rcpt | |
| SCN4A | Ion channel | yes | Na_channel_asu, Ion_trans_dom, Na_channel_a4su_mammal | |
| SCN5A | Ion channel | yes | Na_channel_asu, Ion_trans_dom, Na_channel_a5su | |
| SCN8A | Ion channel | yes | IQ_motif_EF-hand-BS, Na_channel_asu, Ion_trans_dom | |
| SLC35A3 | Other/Unknown | no | Nuc_sug_transpt, EmrE-like | |
| TMPO | Other/Unknown | no | LEM_dom, LEM/LEM-like_dom_sf, LEM-like_dom | |
| ACTA1 | Other/Unknown | no | Actin, Actin_CS, Actin/actin-like_CS | |
| AVEN | Other/Unknown | no | Aven | |
| GFRA4 | Other/Unknown | no | GDNF_rcpt, GDNF/GAS1, GDNF_alpha | |
| ADGRG6 | GPCR | yes | GPS, GPCR_2_secretin-like, CUB_dom | |
| ZEB2 | Transcription factor | no | HD, Di19_Zn-bd, Homeodomain-like_sf | |
| SETBP1 | Other/Unknown | no | AT_hook_DNA-bd_motif | |
| KIF1B | Scaffold/PPI | no | FHA_dom, Kinesin_motor_dom, PH_domain | |
| PRICKLE1 | Transcription factor | no | Znf_LIM, PET_domain, PET_prickle | |
| BICD2 | Other/Unknown | no | BICD | |
| COL25A1 | Other/Unknown | no | Collagen, Collagen_Structural_Proteins | |
| LGI4 | Other/Unknown | no | Cys-rich_flank_reg_C, Leu-rich_rpt, Leu-rich_rpt_typical-subtyp | |
| ASPM | Antibody/Immunoglobulin | yes | IQ_motif_EF-hand-BS, CH_dom, ARM-like | |
| NALCN | Ion channel | yes | Ion_trans_dom, Volt_channel_dom_sf, NALCN | |
| CHRND | Other/Unknown | no | Nicotinic_acetylcholine_rcpt, Neurotrans-gated_channel_TM, Neur_channel | |
| CHRNG | Other/Unknown | no | Nicotinic_acetylcholine_rcpt, Neurotrans-gated_channel_TM, Neur_channel | |
| ADSS1 | Enzyme (other) | yes | 6.3.4.4 | Adenylosuccinate_synthetase, Adenylosuccin_syn_GTP-bd, P-loop_NTPase |
| DQX1 | Other/Unknown | no | Helicase-assoc_dom, DEAD-box_helicase_OB_fold, Helicase_ATP-bd | |
| SPAG16 | Scaffold/PPI | no | WD40_rpt, WD40/YVTN_repeat-like_dom_sf, WD40_repeat_CS | |
| VPS13D | Other/Unknown | no | UBA-like_sf, VPS13_VAB, UBA | |
| ASCC1 | Other/Unknown | no | KH_dom_type_1, Cyclic_Pdiesterase, ASCC1 | |
| PIEZO2 | Other/Unknown | no | Piezo, Piezo_cap_dom, Piezo_TM25-28 | |
| BLTP1 | Other/Unknown | no | BLTP1, BLTP1_N, BLTP1_M | |
| IQSEC3 | Other/Unknown | no | Sec7_dom, PH-like_dom_sf, Sec7_C_sf | |
| ERGIC1 | Other/Unknown | no | Erv_C, Erv_N, Erv | |
| EARS2 | Other/Unknown | no | Glu/Gln-tRNA-synth, aa-tRNA-synth_I_CS, Glu-tRNA-ligase_bac/mito | |
| SH3TC2 | Scaffold/PPI | no | SH3_domain, TPR-like_helical_dom_sf, TPR_rpt | |
| GLDN | Other/Unknown | no | Olfac-like_dom, Collagen, Olfactomedin-like_domain | |
| DYNC1H1 | Other/Unknown | no | AAA+_ATPase, Dhc_D6_P-loop, Dynein_heavy_tail | |
| MAGI3 | Kinase | yes | WW_dom, PDZ, Guanylate_kin-like_dom | |
| SEPSECS | Enzyme (other) | yes | 2.9.1.2 | SepSecS/SepCysS, PyrdxlP-dep_Trfase_major, PyrdxlP-dep_Trfase |
| ECEL1 | Protease | yes | Peptidase_M13, Peptidase_M13_N, Peptidase_M13_C | |
| F9 | Protease | yes | 3.4.21.22 | EGF-type_Asp/Asn_hydroxyl_site, GLA_domain, EGF |
| FBLN1 | Complement | yes | Anaphylatoxin/fibulin, EGF-type_Asp/Asn_hydroxyl_site, EGF | |
| FZD3 | GPCR | yes | Frizzled/Smoothened_7TM, Frizzled/SFRP, GPCR_2-like_7TM | |
| ALDH5A1 | Enzyme (other) | yes | 1.2.1.24 | Succ_semiAld_DH, Aldehyde_DH_dom, Ald_DH_CS_CYS |
| GBE1 | Antibody/Immunoglobulin | yes | Glyco_hydro_13_N, GH13_cat_dom, A-amylase/branching_C | |
| GCN1 | Other/Unknown | no | ARM-like, ARM-type_fold, HEAT_type_2 | |
| ZNF875 | Transcription factor | no | KRAB, Znf_C2H2_type, KRAB_dom_sf | |
| ASAH1 | Enzyme (other) | yes | 3.5.1.23 | Acid_ceramidase-like, Acid_ceramidase_N, CBAH/NAAA_C |
Expression context
Cohort genes with no expression data: 0.
48 cohort genes are a single-cell marker in ≥1 SCXA experiment.
Breadth distribution (Bgee present_calls)
| Bucket | Genes |
|---|---|
| narrow (1-5 tissues) | 0 |
| moderate (6-20) | 0 |
| broad (>20) | 57 |
| unknown | 0 |
Top tissues across cohort
| Tissue | Cohort genes |
|---|---|
| ventricular zone | 6 |
| gastrocnemius | 5 |
| Brodmann (1909) area 23 | 5 |
| sural nerve | 5 |
| calcaneal tendon | 4 |
| gluteal muscle | 4 |
| hindlimb stylopod muscle | 4 |
| corpus callosum | 4 |
| adrenal tissue | 3 |
| skeletal muscle tissue of rectus abdominis | 3 |
| middle temporal gyrus | 3 |
| skeletal muscle tissue of biceps brachii | 3 |
| male germ line stem cell (sensu Vertebrata) in testis | 3 |
| biceps brachii | 3 |
| secondary oocyte | 3 |
| pancreatic ductal cell | 3 |
| right lobe of liver | 3 |
| adenohypophysis | 2 |
| dorsal root ganglion | 2 |
| pons | 2 |
Per-gene tissue summary (top 30)
| Symbol | Bgee breadth | FANTOM5 breadth | SCXA | Top tissues |
|---|---|---|---|---|
| UNC50 | 294 | ubiquitous | marker | palpebral conjunctiva, adenohypophysis, left lobe of thyroid gland |
| KIF21A | 253 | ubiquitous | marker | dorsal root ganglion, substantia nigra pars compacta, pons |
| VPS8 | 283 | ubiquitous | marker | adrenal tissue, calcaneal tendon, colonic epithelium |
| SENP7 | 261 | ubiquitous | marker | calcaneal tendon, adrenal tissue, left ovary |
| ROR2 | 188 | ubiquitous | marker | muscle layer of sigmoid colon, mucosa of stomach, body of uterus |
| RYR1 | 214 | broad | marker | gluteal muscle, gastrocnemius, hindlimb stylopod muscle |
| SCN4A | 153 | tissue_specific | yes | hindlimb stylopod muscle, gastrocnemius, skeletal muscle tissue of rectus abdominis |
| SCN5A | 161 | broad | yes | apex of heart, heart left ventricle, cardiac ventricle |
| SCN8A | 194 | ubiquitous | marker | Brodmann (1909) area 23, middle temporal gyrus, postcentral gyrus |
| SLC35A3 | 287 | ubiquitous | marker | mucosa of sigmoid colon, jejunal mucosa, colonic mucosa |
| TMPO | 287 | ubiquitous | marker | ventricular zone, ganglionic eminence, embryo |
| ACTA1 | 203 | broad | marker | gluteal muscle, skeletal muscle tissue of biceps brachii, diaphragm |
| AVEN | 252 | ubiquitous | marker | heart right ventricle, cervix squamous epithelium, ascending aorta |
| GFRA4 | 36 | yes | male germ line stem cell (sensu Vertebrata) in testis, diaphragm, olfactory bulb | |
| ADGRG6 | 247 | ubiquitous | marker | endometrium epithelium, amniotic fluid, placenta |
| ZEB2 | 290 | ubiquitous | marker | cortical plate, sural nerve, monocyte |
| SETBP1 | 280 | ubiquitous | marker | ventricular zone, buccal mucosa cell, caput epididymis |
| KIF1B | 287 | ubiquitous | marker | skeletal muscle tissue of rectus abdominis, biceps brachii, medial globus pallidus |
| PRICKLE1 | 243 | ubiquitous | marker | buccal mucosa cell, tendon of biceps brachii, lateral nuclear group of thalamus |
| BICD2 | 290 | ubiquitous | marker | gingival epithelium, gingiva, hair follicle |
| COL25A1 | 163 | broad | marker | sperm, left testis, right testis |
| LGI4 | 214 | broad | marker | peripheral nervous system, nerve, tibial nerve |
| ASPM | 176 | ubiquitous | marker | oocyte, ventricular zone, secondary oocyte |
| NALCN | 201 | ubiquitous | marker | middle temporal gyrus, Brodmann (1909) area 23, corpus callosum |
| CHRND | 86 | tissue_specific | yes | gastrocnemius, muscle of leg, hindlimb stylopod muscle |
| CHRNG | 54 | tissue_specific | marker | pancreatic ductal cell, gastrocnemius, muscle of leg |
| ADSS1 | 242 | ubiquitous | marker | quadriceps femoris, vastus lateralis, skeletal muscle tissue of rectus abdominis |
| DQX1 | 154 | tissue_specific | marker | mucosa of transverse colon, rectum, jejunal mucosa |
| SPAG16 | 289 | ubiquitous | marker | bronchial epithelial cell, epithelium of bronchus, bronchus |
| VPS13D | 299 | ubiquitous | marker | skin of leg, skin of abdomen, sural nerve |
Protein interactions among cohort
Intra-cohort edges: 15.
Hub genes (top 10 by interactor count)
| Symbol | Interactor count |
|---|---|
| ALDH5A1 | 4,219 |
| DYNC1H1 | 4,215 |
| GCN1 | 3,919 |
| MAGI3 | 3,725 |
| EARS2 | 3,667 |
| MYOD1 | 3,624 |
| GBE1 | 3,402 |
| ATP2B3 | 3,203 |
| ZEB2 | 3,193 |
| ASPM | 2,949 |
Intra-cohort edges
| A | B | Sources |
|---|---|---|
| ADGRG6 | LGI4 | string_interaction |
| ADGRG6 | SCN4A | intact |
| ASAH1 | NAGA | string_interaction |
| BICD2 | DYNC1H1 | string_interaction |
| CHRND | ECEL1 | string_interaction |
| CHRND | RAPSN | string_interaction |
| CHRNG | ECEL1 | string_interaction |
| CHRNG | RAPSN | string_interaction |
| CNTNAP1 | GLDN | string_interaction |
| CNTNAP1 | LGI4 | string_interaction |
| ECEL1 | PIEZO2 | string_interaction |
| FZD3 | PRICKLE1 | string_interaction |
| MAGI3 | SCN4A | intact |
| MAGI3 | SCN8A | intact |
| MYH3 | MYOD1 | string_interaction |
Structural data
PDB: 27 · AlphaFold-only: 30 · No structure: 0
Cohort genes with PDB structures (top 30)
| Symbol | UniProt | PDB entries |
|---|---|---|
| DYNC1H1 | Q14204 | 97 |
| F9 | P00740 | 56 |
| SCN5A | Q14524 | 16 |
| TMPO | P42166 | 14 |
| CHRND | Q07001 | 13 |
| SCN8A | Q9UQD0 | 7 |
| SEPSECS | Q9HD40 | 7 |
| NAGA | P17050 | 7 |
| ROR2 | Q01974 | 6 |
| KIF21A | Q7Z4S6 | 5 |
| ACTA1 | P68133 | 5 |
| NALCN | Q8IZF0 | 5 |
| ALDH5A1 | P51649 | 5 |
| FZD3 | Q9NPG1 | 4 |
| SCN4A | P35499 | 3 |
| GBE1 | Q04446 | 3 |
| SENP7 | Q9BQF6 | 2 |
| RYR1 | P21817 | 2 |
| BICD2 | Q8TD16 | 2 |
| PIEZO2 | Q9H5I5 | 2 |
| ASAH1 | Q13510 | 2 |
| ADGRG6 | Q86SQ4 | 1 |
| ZEB2 | O60315 | 1 |
| KIF1B | O60333 | 1 |
| ASCC1 | Q8N9N2 | 1 |
| GLDN | Q6ZMI3 | 1 |
| MAGI3 | Q5TCQ9 | 1 |
AlphaFold-only cohort genes (top 30 by pLDDT)
| Symbol | UniProt | pLDDT |
|---|---|---|
| RAPSN | Q13702 | 93.29 |
| ADSS1 | Q8N142 | 93.10 |
| LGI4 | Q8N135 | 92.80 |
| EARS2 | Q5JPH6 | 89.84 |
| SLC35A3 | Q9Y2D2 | 89.31 |
| ERGIC1 | Q969X5 | 88.96 |
| UNC50 | Q53HI1 | 88.86 |
| ECEL1 | O95672 | 88.62 |
| DQX1 | Q8TE96 | 87.42 |
| GCN1 | Q92616 | 82.45 |
| CHRNG | P07510 | 81.91 |
| CNTNAP1 | P78357 | 81.51 |
| FBLN1 | P23142 | 79.49 |
| SH3TC2 | Q8TF17 | 78.63 |
| SPAG16 | Q8N0X2 | 77.12 |
| VPS8 | Q8N3P4 | 74.77 |
| ATP2B3 | Q16720 | 74.57 |
| MYH3 | P11055 | 74.35 |
| GFRA4 | Q9GZZ7 | 69.21 |
| ZNF875 | P10072 | 66.73 |
| MYOD1 | P15172 | 62.04 |
| AVEN | Q9NQS1 | 58.86 |
| IQSEC3 | Q9UPP2 | 58.76 |
| COL25A1 | Q9BXS0 | 57.23 |
| PRICKLE1 | Q96MT3 | 55.55 |
| PRG4 | Q92954 | 48.76 |
| SETBP1 | Q9Y6X0 | 43.30 |
| ASPM | Q8IZT6 | |
| VPS13D | Q5THJ4 | |
| BLTP1 | Q2LD37 |
Function
Pathway analysis
Distinct Reactome pathways touched by cohort: 162. Enrichment computed across 57 evidence-associated genes (39 with Reactome annotation).
Pathways by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 39 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| Pathway | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| Muscle contraction | 7 | 13.8× | 9e-05 | RYR1, SCN4A, SCN5A, SCN8A, ACTA1, MYH3, ATP2B3 |
| Cardiac conduction | 5 | 13.9× | 0.002 | RYR1, SCN4A, SCN5A, SCN8A, ATP2B3 |
| Interaction between L1 and Ankyrins | 3 | 28.3× | 0.008 | SCN4A, SCN5A, SCN8A |
| Phase 0 - rapid depolarisation | 3 | 26.6× | 0.008 | SCN4A, SCN5A, SCN8A |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | 2 | 83.7× | 0.008 | CHRND, CHRNG |
| Presynaptic nicotinic acetylcholine receptors | 2 | 48.8× | 0.020 | CHRND, CHRNG |
| Acetylcholine binding and downstream events | 2 | 41.8× | 0.020 | CHRND, CHRNG |
| Postsynaptic nicotinic acetylcholine receptors | 2 | 41.8× | 0.020 | CHRND, CHRNG |
| Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS) | 1 | 292.8× | 0.050 | SLC35A3 |
| Defective F9 secretion | 1 | 292.8× | 0.050 | F9 |
| Golgi-to-ER retrograde transport | 3 | 10.2× | 0.050 | KIF1B, BICD2, KIF21A |
| L1CAM interactions | 3 | 9.2× | 0.055 | SCN4A, SCN5A, SCN8A |
| Degradation of GABA | 1 | 146.4× | 0.069 | ALDH5A1 |
| Defective gamma-carboxylation of F9 | 1 | 146.4× | 0.069 | F9 |
| Striated Muscle Contraction | 2 | 15.8× | 0.069 | ACTA1, MYH3 |
| PCP/CE pathway | 2 | 15.4× | 0.069 | ROR2, FZD3 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | 3 | 8.1× | 0.069 | KIF1B, BICD2, KIF21A |
| Ion channel transport | 3 | 7.4× | 0.069 | RYR1, NALCN, ATP2B3 |
| Glycogen storage disease type IV (GBE1) | 1 | 97.6× | 0.075 | GBE1 |
| Defective factor IX causes thrombophilia | 1 | 97.6× | 0.075 | F9 |
| Defective cofactor function of FVIIIa variant | 1 | 97.6× | 0.075 | F9 |
| Defective F9 variant does not activate FX | 1 | 97.6× | 0.075 | F9 |
| Nervous system development | 4 | 4.4× | 0.088 | SCN4A, SCN5A, SCN8A, ADGRG6 |
| ALKBH3 mediated reversal of alkylation damage | 1 | 73.2× | 0.090 | ASCC1 |
| COPI-independent Golgi-to-ER retrograde traffic | 2 | 10.7× | 0.090 | BICD2, DYNC1H1 |
| Asymmetric localization of PCP proteins | 2 | 10.5× | 0.090 | PRICKLE1, FZD3 |
| Ion homeostasis | 2 | 10.5× | 0.090 | RYR1, ATP2B3 |
| Transmission across Chemical Synapses | 3 | 5.9× | 0.090 | CHRND, CHRNG, ALDH5A1 |
| Developmental Biology | 7 | 2.6× | 0.091 | SCN4A, SCN5A, SCN8A, ADGRG6, LGI4, ASAH1, MYOD1 |
| Defective F9 activation | 1 | 48.8× | 0.106 | F9 |
GO biological processes by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 55 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| GO term | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| muscle contraction | 6 | 22.7× | 1e-04 | RYR1, SCN4A, ACTA1, CHRND, CHRNG, MYH3 |
| myelination in peripheral nervous system | 3 | 48.4× | 0.006 | ADGRG6, LGI4, CNTNAP1 |
| cardiac muscle cell action potential involved in contraction | 3 | 38.3× | 0.008 | SCN4A, SCN5A, SCN8A |
| skeletal muscle fiber development | 3 | 29.6× | 0.008 | RYR1, ACTA1, MYOD1 |
| skeletal muscle contraction | 3 | 27.9× | 0.008 | CHRND, CHRNG, MYH3 |
| membrane depolarization | 3 | 27.9× | 0.008 | SCN5A, CHRND, CHRNG |
| monoatomic ion transmembrane transport | 4 | 15.1× | 0.008 | NALCN, CHRND, CHRNG, ATP2B3 |
| sodium ion transmembrane transport | 4 | 14.8× | 0.008 | SCN4A, SCN5A, SCN8A, NALCN |
| protein targeting to vacuole | 2 | 47.1× | 0.035 | VPS13D, VPS8 |
| sodium ion transport | 3 | 14.8× | 0.043 | SCN4A, SCN5A, SCN8A |
| negative regulation of asymmetric cell division | 1 | 306.4× | 0.052 | ASPM |
| mammillary axonal complex development | 1 | 306.4× | 0.052 | ZEB2 |
| regulation of programmed necrotic cell death | 1 | 306.4× | 0.052 | ASAH1 |
| tRNA aminoacylation for mitochondrial protein translation | 1 | 306.4× | 0.052 | EARS2 |
| neuromuscular junction development, skeletal muscle fiber | 1 | 306.4× | 0.052 | CNTNAP1 |
| regulation of skeletal muscle contraction by action potential | 1 | 306.4× | 0.052 | SCN4A |
| regulation of ERBB signaling pathway | 1 | 306.4× | 0.052 | SH3TC2 |
| regulation of postsynaptic membrane organization | 1 | 306.4× | 0.052 | RAPSN |
| establishment of protein localization to postsynaptic membrane | 1 | 306.4× | 0.052 | RAPSN |
| negative regulation of transformation of host cell by virus | 1 | 306.4× | 0.052 | FBLN1 |
| positive regulation of myofibroblast contraction | 1 | 306.4× | 0.052 | ZEB2 |
| regulation of blood-brain barrier permeability | 1 | 306.4× | 0.052 | ZEB2 |
| conversion of seryl-tRNAsec to selenocys-tRNAsec | 1 | 153.2× | 0.052 | SEPSECS |
| glutamyl-tRNA aminoacylation | 1 | 153.2× | 0.052 | EARS2 |
| myoblast fate determination | 1 | 153.2× | 0.052 | MYOD1 |
| GABA catabolic process | 1 | 153.2× | 0.052 | ALDH5A1 |
| glycolipid catabolic process | 1 | 153.2× | 0.052 | NAGA |
| forebrain neuroblast division | 1 | 153.2× | 0.052 | ASPM |
| microvillus organization | 1 | 153.2× | 0.052 | GLDN |
| negative regulation of mitotic cell cycle, embryonic | 1 | 153.2× | 0.052 | FZD3 |
Therapeutics
Drug target analysis
Approved (phase 4): 5 · Phase ≥3: 5 · Phased (≥1): 9 · Undrugged: 48
Druggability breadth: 21 of 57 evidence-associated genes (37%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).
Genes with an approved drug
The molecule shown is one approved compound that hits the gene — not necessarily a drug of choice or one indicated for this disease.
| Symbol | Example approved molecule |
|---|---|
| SCN4A | CARBAMAZEPINE |
| SCN5A | BEPRIDIL |
| SCN8A | IMIPRAMINE |
| CHRND | VARENICLINE |
| CHRNG | VARENICLINE |
Top cohort targets by molecule count
| Symbol | Molecules | Max phase |
|---|---|---|
| SCN5A | 108 | 4 |
| SCN8A | 25 | 4 |
| SCN4A | 24 | 4 |
| CHRND | 10 | 4 |
| CHRNG | 10 | 4 |
| F9 | 2 | 2 |
| SENP7 | 1 | 2 |
| DYNC1H1 | 1 | 2 |
| ASAH1 | 1 | 2 |
| UNC50 | 0 | 0 |
Drugs targeting cohort genes (top 30)
| Molecule | Max phase | Targets in cohort |
|---|---|---|
| CARBAMAZEPINE | 4 | SCN4A, SCN5A |
| PHENYTOIN | 4 | SCN4A, SCN5A |
| LAMOTRIGINE | 4 | SCN4A, SCN5A |
| RILUZOLE | 4 | SCN4A, SCN5A |
| LIDOCAINE | 4 | SCN4A, SCN5A |
| IMIPRAMINE | 4 | SCN4A, SCN5A, SCN8A |
| SERTINDOLE | 4 | SCN4A, SCN5A, SCN8A |
| PIMOZIDE | 4 | SCN4A, SCN5A, SCN8A |
| NIFEDIPINE | 4 | SCN4A, SCN5A, SCN8A |
| DILTIAZEM | 4 | SCN4A, SCN5A, SCN8A |
| MIBEFRADIL | 4 | SCN4A, SCN5A, SCN8A |
| HALOPERIDOL | 4 | SCN4A, SCN5A, SCN8A |
| MEXILETINE | 4 | SCN4A, SCN5A, SCN8A |
| AMITRIPTYLINE | 4 | SCN4A, SCN5A, SCN8A |
| AMIODARONE | 4 | SCN4A, SCN5A, SCN8A |
| CHLORPROMAZINE | 4 | SCN4A, SCN5A, SCN8A |
| BEPRIDIL | 4 | SCN5A |
| CANDESARTAN CILEXETIL | 4 | SCN5A |
| TELMISARTAN | 4 | SCN5A |
| DIBUCAINE | 4 | SCN5A |
| DROPERIDOL | 4 | SCN5A |
| PONATINIB | 4 | SCN5A |
| DULOXETINE | 4 | SCN5A |
| PALONOSETRON | 4 | SCN5A |
| VILANTEROL | 4 | SCN5A |
| MEXILETINE HYDROCHLORIDE | 4 | SCN5A |
| UNOPROSTONE ISOPROPYL | 4 | SCN5A |
| LURASIDONE | 4 | SCN5A |
| LETERMOVIR | 4 | SCN5A |
| FEDRATINIB | 4 | SCN5A |
Bioactivity and enzyme data
Enzyme cohort genes (≥1 EC): 9.
Cohort genes with ChEMBL bioactivity (full, sorted by assay count)
| Symbol | Assays | Type breakdown |
|---|---|---|
| SCN5A | 594 | Binding:380, Functional:98, ADMET:72, Toxicity:43, Unclassified:1 |
| SCN8A | 173 | Binding:148, Functional:16, ADMET:7, Toxicity:2 |
| ASAH1 | 111 | Binding:108, Functional:3 |
| F9 | 108 | Binding:107, ADMET:1 |
| SCN4A | 95 | Binding:69, Functional:18, ADMET:7, Toxicity:1 |
| CHRND | 75 | Binding:44, Functional:31 |
| CHRNG | 67 | Binding:36, Functional:31 |
| RYR1 | 16 | Binding:13, Functional:3 |
| GCN1 | 12 | Binding:8, Functional:4 |
| TMPO | 7 | Binding:7 |
| DYNC1H1 | 7 | Binding:7 |
| SENP7 | 6 | Functional:3, Binding:3 |
| ALDH5A1 | 5 | Binding:5 |
| KIF21A | 4 | Binding:3, Toxicity:1 |
| ROR2 | 4 | Binding:4 |
| MAGI3 | 4 | Binding:4 |
| NAGA | 4 | Binding:4 |
| ADGRG6 | 2 | Binding:2 |
| KIF1B | 1 | Binding:1 |
| ERGIC1 | 1 | Binding:1 |
| RAPSN | 1 | Binding:1 |
Cohort enzymes (BRENDA EC)
| Symbol | EC numbers | Names |
|---|---|---|
| SENP7 | 3.4.22.B75 | |
| ROR2 | 2.7.10.1 | receptor protein-tyrosine kinase |
| ADSS1 | 6.3.4.4 | adenylosuccinate synthase |
| SEPSECS | 2.9.1.2 | O-phospho-L-seryl-tRNASec:L-selenocysteinyl-tRNA synthase |
| F9 | 3.4.21.22 | coagulation factor IXa |
| ALDH5A1 | 1.2.1.24 | succinate-semialdehyde dehydrogenase (NAD+) |
| ASAH1 | 3.5.1.23 | ceramidase |
| NAGA | 3.2.1.49 | alpha-N-acetylgalactosaminidase |
| ATP2B3 | 7.2.2.10 | P-type Ca2+ transporter |
Cohort genes with high screening signal
≥100 ChEMBL assays — a studied-ness signal; see Therapeutics for approved-drug status.
| Symbol | ChEMBL assays |
|---|---|
| SCN5A | 594 |
| SCN8A | 173 |
| F9 | 108 |
| ASAH1 | 111 |
Pharmacogenomics
Cohort genes with a PharmGKB record: 57; with CPIC/DPWG dosing guidelines: 1.
Cohort genes with a CPIC/DPWG dosing guideline
| Symbol | CPIC guidelines |
|---|---|
| RYR1 | 1 |
Chemical tractability of cohort targets
30 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.
| Compound | Max phase | Cohort target (bioactivity) |
|---|---|---|
| CARBAMAZEPINE | 4 | SCN4A, SCN5A |
| PHENYTOIN | 4 | SCN4A, SCN5A |
| LAMOTRIGINE | 4 | SCN4A, SCN5A |
| RILUZOLE | 4 | SCN4A, SCN5A |
| LIDOCAINE | 4 | SCN4A, SCN5A |
| IMIPRAMINE | 4 | SCN4A, SCN5A, SCN8A |
| SERTINDOLE | 4 | SCN4A, SCN5A, SCN8A |
| PIMOZIDE | 4 | SCN4A, SCN5A, SCN8A |
| NIFEDIPINE | 4 | SCN4A, SCN5A, SCN8A |
| DILTIAZEM | 4 | SCN4A, SCN5A, SCN8A |
| MIBEFRADIL | 4 | SCN4A, SCN5A, SCN8A |
| HALOPERIDOL | 4 | SCN4A, SCN5A, SCN8A |
| MEXILETINE | 4 | SCN4A, SCN5A, SCN8A |
| AMITRIPTYLINE | 4 | SCN4A, SCN5A, SCN8A |
| AMIODARONE | 4 | SCN4A, SCN5A, SCN8A |
| CHLORPROMAZINE | 4 | SCN4A, SCN5A, SCN8A |
| BEPRIDIL | 4 | SCN5A |
| CANDESARTAN CILEXETIL | 4 | SCN5A |
| TELMISARTAN | 4 | SCN5A |
| DIBUCAINE | 4 | SCN5A |
| DROPERIDOL | 4 | SCN5A |
| PONATINIB | 4 | SCN5A |
| DULOXETINE | 4 | SCN5A |
| PALONOSETRON | 4 | SCN5A |
| VILANTEROL | 4 | SCN5A |
| MEXILETINE HYDROCHLORIDE | 4 | SCN5A |
| UNOPROSTONE ISOPROPYL | 4 | SCN5A |
| LURASIDONE | 4 | SCN5A |
| LETERMOVIR | 4 | SCN5A |
| FEDRATINIB | 4 | SCN5A |
Druggability pyramid
Cohort genes binned by druggability tier (high → low):
| Tier | Definition | Genes | Symbols |
|---|---|---|---|
| A | Approved (phase 4 drug) | 5 | SCN4A, SCN5A, SCN8A, CHRND, CHRNG |
| B | Phased (≥1) drug, not yet approved | 4 | SENP7, DYNC1H1, F9, ASAH1 |
| C | Druggable family + PDB, no drug | 10 | ROR2, RYR1, ADGRG6, NALCN, MAGI3, SEPSECS, FZD3, ALDH5A1, GBE1, NAGA |
| D | Druggable family + AlphaFold only, no drug | 4 | ASPM, ADSS1, ECEL1, FBLN1 |
| E | Difficult family or no structure, no drug | 34 | UNC50, KIF21A, VPS8, SLC35A3, TMPO, ACTA1, AVEN, GFRA4, ZEB2, SETBP1 (+24 more) |
Undrugged target profiles
48 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).
| Symbol | ChEMBL assays | Drugged partners (top 3) |
|---|---|---|
| ECEL1 | 0 | CHRND, CHRNG |
| RAPSN | 1 | CHRND |
| UNC50 | 0 | — |
| KIF21A | 4 | — |
| VPS8 | 0 | — |
| ROR2 | 4 | — |
| RYR1 | 16 | — |
| SLC35A3 | 0 | — |
| TMPO | 7 | — |
| ACTA1 | 0 | — |
| AVEN | 0 | — |
| GFRA4 | 0 | — |
| ADGRG6 | 2 | — |
| ZEB2 | 0 | — |
| SETBP1 | 0 | — |
| KIF1B | 1 | — |
| PRICKLE1 | 0 | — |
| BICD2 | 0 | — |
| COL25A1 | 0 | — |
| LGI4 | 0 | — |
| ASPM | 0 | — |
| NALCN | 0 | — |
| ADSS1 | 0 | — |
| DQX1 | 0 | — |
| SPAG16 | 0 | — |
| VPS13D | 0 | — |
| ASCC1 | 0 | — |
| PIEZO2 | 0 | — |
| BLTP1 | 0 | — |
| IQSEC3 | 0 | — |
Clinical trials & evidence
Clinical trials
Clinical trials: 4.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 4 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT07360574 | Not specified | NOT_YET_RECRUITING | Piezo2-related Arthrogryposis & physiopathOLOgy 3 |
| NCT05393375 | Not specified | COMPLETED | Arthrogryposis Multiplex Congenita in Pediatric Age: Correlation Between MUScular MRI and Functional Evaluation |
| NCT05673265 | Not specified | UNKNOWN | Pediatric and Adult Registry for Patients With ARThrogryposis |
| NCT06130592 | Not specified | UNKNOWN | Technical Feasibility Study of Ultrasound Muscle Imaging in Antenatal Ultrasound |
Related Atlas pages
- Cohort genes: UNC50, KIF21A, VPS8, SENP7, ROR2, RYR1, SCN4A, SCN5A, SCN8A, SLC35A3, TMPO, ACTA1, AVEN, GFRA4, ADGRG6, ZEB2, SETBP1, KIF1B, PRICKLE1, BICD2, COL25A1, LGI4, ASPM, NALCN, CHRND, CHRNG, ADSS1, DQX1, SPAG16, VPS13D, ASCC1, PIEZO2, BLTP1, IQSEC3, ERGIC1, EARS2, SH3TC2, GLDN, DYNC1H1, MAGI3, SEPSECS, ECEL1, F9, FBLN1, FZD3, ALDH5A1, GBE1, GCN1, ZNF875, ASAH1, MYH3, MYOD1, NAGA, CNTNAP1, ATP2B3, PRG4, RAPSN